drug_name,target
pravastatin,Histone deacetylase 2 inhibitor
fluvoxamine,Sodium-dependent serotonin transporter inhibitor
fluvoxamine,Potassium voltage-gated channel subfamily H member 2 inhibitor
valsartan,Type-1 angiotensin II receptor antagonist
ramipril,Angiotensin-converting enzyme inhibitor
flunisolide,Glucocorticoid receptor agonist
amphetamine,Synaptic vesicular amine transporter inhibitor
amphetamine,Sodium-dependent dopamine transporter inhibitor
amphetamine,Sodium-dependent dopamine transporter agonist
amphetamine,Sodium-dependent dopamine transporter binder
amphetamine,Sodium-dependent noradrenaline transporter inhibitor
amphetamine,Sodium-dependent noradrenaline transporter agonist
amphetamine,Sodium-dependent noradrenaline transporter binder
amphetamine,Beta adrenergic receptor inhibitor
amphetamine,Dopamine D2 receptor inhibitor
amphetamine,Dopamine D2 receptor agonist
amphetamine,Dopamine D2 receptor binder
amphetamine,Amine oxidase [flavin-containing] B inhibitor
amphetamine,Sodium-dependent serotonin transporter inhibitor
amphetamine,Sodium-dependent serotonin transporter agonist
amphetamine,Sodium-dependent serotonin transporter binder
nicotine,Neuronal acetylcholine receptor subunit alpha-4 agonist
nicotine,Neuronal acetylcholine receptor subunit alpha-4 inhibitor
cevimeline,Muscarinic acetylcholine receptor M3 agonist
cevimeline,Muscarinic acetylcholine receptor M1 agonist
lorazepam,GABA(A) Receptor ligand
lorazepam,GABA(A) Receptor Benzodiazepine Binding Site ligand
esmolol,Beta-1 adrenergic receptor antagonist
phentermine,Sodium-dependent noradrenaline transporter inhibitor
phentermine,Sodium-dependent noradrenaline transporter antagonist
phentermine,Sodium-dependent serotonin transporter inhibitor
phentermine,Sodium-dependent serotonin transporter antagonist
phentermine,Sodium-dependent dopamine transporter inhibitor
phentermine,Sodium-dependent dopamine transporter antagonist
phentermine,Amine oxidase [flavin-containing] B inhibitor
tramadol,Mu-type opioid receptor agonist
tramadol,Mu-type opioid receptor inhibitor
tramadol,Mu-type opioid receptor antagonist
tramadol,Sodium-dependent noradrenaline transporter agonist
tramadol,Sodium-dependent noradrenaline transporter inhibitor
tramadol,Sodium-dependent noradrenaline transporter antagonist
tramadol,Sodium-dependent serotonin transporter agonist
tramadol,Sodium-dependent serotonin transporter inhibitor
tramadol,Sodium-dependent serotonin transporter antagonist
tramadol,5-hydroxytryptamine receptor 2C agonist
tramadol,5-hydroxytryptamine receptor 2C inhibitor
tramadol,5-hydroxytryptamine receptor 2C antagonist
tramadol,Kappa-type opioid receptor agonist
tramadol,Kappa-type opioid receptor inhibitor
tramadol,Kappa-type opioid receptor antagonist
tramadol,Delta-type opioid receptor agonist
tramadol,Delta-type opioid receptor antagonist
tramadol,Muscarinic acetylcholine receptor M3 agonist
tramadol,Muscarinic acetylcholine receptor M3 inhibitor
tramadol,Muscarinic acetylcholine receptor M3 antagonist
tramadol,Muscarinic acetylcholine receptor M1 agonist
tramadol,Muscarinic acetylcholine receptor M1 inhibitor
tramadol,Muscarinic acetylcholine receptor M1 antagonist
tramadol,Adenosine receptor A1 inhibitor
tramadol,Adenosine receptor A1 antagonist
tramadol,Alpha-2 adrenergic receptors agonist
tramadol,Alpha-2 adrenergic receptors inhibitor
tramadol,Alpha-2 adrenergic receptors antagonist
betaxolol,Beta-1 adrenergic receptor antagonist
betaxolol,Beta-2 adrenergic receptor antagonist
troglitazone,Peroxisome proliferator-activated receptor gamma agonist
troglitazone,Peroxisome proliferator-activated receptor gamma inhibitor
troglitazone,Peroxisome proliferator-activated receptor alpha agonist
troglitazone,Peroxisome proliferator-activated receptor alpha inhibitor
erythromycin,Potassium voltage-gated channel subfamily H member 2 inhibitor
caffeine,Adenosine receptor A1 antagonist
caffeine,Adenosine receptor A1 inhibitor
succinylcholine,Muscarinic acetylcholine receptor M3 agonist
sildenafil,"cGMP-specific 3',5'-cyclic phosphodiesterase inhibitor"
dofetilide,Potassium voltage-gated channel subfamily H member 2 inhibitor
reserpine,Synaptic vesicular amine transporter inhibitor
trospium,Muscarinic acetylcholine receptor M1 antagonist
trospium,Muscarinic acetylcholine receptor M3 antagonist
midodrine,Alpha-1A adrenergic receptor agonist
midodrine,Alpha-1B adrenergic receptor agonist
midodrine,Alpha-1D adrenergic receptor agonist
citalopram,Sodium-dependent serotonin transporter inhibitor
citalopram,Sodium-dependent serotonin transporter binder
citalopram,Histamine H1 receptor inhibitor
citalopram,Histamine H1 receptor binder
eletriptan,5-hydroxytryptamine receptor 1D agonist
eletriptan,5-hydroxytryptamine receptor 1B agonist
eletriptan,5-hydroxytryptamine receptor 1F agonist
eletriptan,5-hydroxytryptamine receptor 1A agonist
moxifloxacin,DNA topoisomerase 4 subunit A inhibitor
moxifloxacin,DNA gyrase subunit A inhibitor
moxifloxacin,DNA topoisomerase 2-alpha inhibitor
indinavir,Human immunodeficiency virus type 1 protease inhibitor
temazepam,GABA(A) Receptor ligand
temazepam,GABA(A) Receptor Benzodiazepine Binding Site ligand
reboxetine,Sodium-dependent noradrenaline transporter inhibitor
milrinone,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A inhibitor"
butabarbital,GABA(A) Receptor inhibitor
butabarbital,GABA(A) Receptor antagonist
cladribine,DNA inhibitor
ranolazine,Alpha-1 adrenergic receptors inhibitor
ranolazine,Alpha-1 adrenergic receptors antagonist
ranolazine,Beta-1 adrenergic receptor inhibitor
ranolazine,Beta-1 adrenergic receptor antagonist
ziprasidone,Dopamine D2 receptor antagonist
ziprasidone,Dopamine D2 receptor agonist
ziprasidone,Dopamine D1 receptor antagonist
ziprasidone,Dopamine D1 receptor agonist
ziprasidone,Dopamine D5 receptor antagonist
ziprasidone,Dopamine D5 receptor agonist
ziprasidone,5-hydroxytryptamine receptor 2A antagonist
ziprasidone,5-hydroxytryptamine receptor 2A agonist
ziprasidone,Dopamine D3 receptor antagonist
ziprasidone,Dopamine D3 receptor agonist
ziprasidone,Dopamine D4 receptor antagonist
ziprasidone,Dopamine D4 receptor agonist
ziprasidone,5-hydroxytryptamine receptor 1A antagonist
ziprasidone,5-hydroxytryptamine receptor 1A agonist
ziprasidone,5-hydroxytryptamine receptor 1B antagonist
ziprasidone,5-hydroxytryptamine receptor 1B agonist
ziprasidone,5-hydroxytryptamine receptor 1D antagonist
ziprasidone,5-hydroxytryptamine receptor 1D agonist
ziprasidone,5-hydroxytryptamine receptor 1E antagonist
ziprasidone,5-hydroxytryptamine receptor 2C antagonist
ziprasidone,5-hydroxytryptamine receptor 2C agonist
ziprasidone,5-hydroxytryptamine receptor 6 antagonist
ziprasidone,5-hydroxytryptamine receptor 7 antagonist
ziprasidone,5-hydroxytryptamine receptor 7 agonist
ziprasidone,Histamine H1 receptor antagonist
ziprasidone,Histamine H1 receptor agonist
ziprasidone,Alpha-1A adrenergic receptor antagonist
ziprasidone,Alpha-1A adrenergic receptor agonist
ziprasidone,Alpha-1B adrenergic receptor antagonist
ziprasidone,Alpha-1B adrenergic receptor agonist
ziprasidone,Alpha-2A adrenergic receptor antagonist
ziprasidone,Alpha-2A adrenergic receptor agonist
ziprasidone,Alpha-2B adrenergic receptor antagonist
ziprasidone,Alpha-2B adrenergic receptor agonist
ziprasidone,Alpha-2C adrenergic receptor antagonist
ziprasidone,Alpha-2C adrenergic receptor agonist
ziprasidone,Muscarinic acetylcholine receptor M1 antagonist
ziprasidone,Muscarinic acetylcholine receptor M1 agonist
ziprasidone,Muscarinic acetylcholine receptor M2 antagonist
ziprasidone,Muscarinic acetylcholine receptor M3 antagonist
ziprasidone,Muscarinic acetylcholine receptor M3 agonist
ziprasidone,Muscarinic acetylcholine receptor M4 antagonist
ziprasidone,Muscarinic acetylcholine receptor M5 antagonist
methysergide,5-hydroxytryptamine receptor 2B antagonist
methysergide,5-hydroxytryptamine receptor 2B agonist
methysergide,5-hydroxytryptamine receptor 2B binder
methysergide,5-hydroxytryptamine receptor 2C antagonist
methysergide,5-hydroxytryptamine receptor 2C agonist
methysergide,5-hydroxytryptamine receptor 2C binder
methysergide,5-hydroxytryptamine receptor 2A antagonist
methysergide,5-hydroxytryptamine receptor 2A agonist
methysergide,5-hydroxytryptamine receptor 2A binder
methysergide,5-hydroxytryptamine receptor 1A antagonist
methysergide,5-hydroxytryptamine receptor 1A agonist
methysergide,5-hydroxytryptamine receptor 1A binder
methysergide,5-hydroxytryptamine receptor 7 antagonist
methysergide,5-hydroxytryptamine receptor 7 agonist
methysergide,5-hydroxytryptamine receptor 7 binder
methysergide,5-hydroxytryptamine receptor 1B antagonist
methysergide,5-hydroxytryptamine receptor 1B agonist
methysergide,5-hydroxytryptamine receptor 1F agonist
methysergide,5-hydroxytryptamine receptor 1E antagonist
cabergoline,Dopamine D2 receptor agonist
cabergoline,Dopamine D2 receptor antagonist
cabergoline,Dopamine D2 receptor binder
cabergoline,5-hydroxytryptamine receptor 2B agonist
cabergoline,5-hydroxytryptamine receptor 2B antagonist
cabergoline,5-hydroxytryptamine receptor 2B binder
cabergoline,Dopamine D3 receptor agonist
cabergoline,Dopamine D3 receptor antagonist
cabergoline,Dopamine D3 receptor binder
cabergoline,5-hydroxytryptamine receptor 2A agonist
cabergoline,5-hydroxytryptamine receptor 2A antagonist
cabergoline,5-hydroxytryptamine receptor 2A binder
cabergoline,Alpha-2B adrenergic receptor agonist
cabergoline,Alpha-2B adrenergic receptor antagonist
cabergoline,Alpha-2B adrenergic receptor binder
cabergoline,5-hydroxytryptamine receptor 1D agonist
cabergoline,5-hydroxytryptamine receptor 1D antagonist
cabergoline,Dopamine D4 receptor agonist
cabergoline,Dopamine D4 receptor antagonist
cabergoline,Alpha-2A adrenergic receptor agonist
cabergoline,Alpha-2A adrenergic receptor antagonist
cabergoline,Alpha-2A adrenergic receptor binder
cabergoline,5-hydroxytryptamine receptor 1A agonist
cabergoline,5-hydroxytryptamine receptor 1A antagonist
cabergoline,5-hydroxytryptamine receptor 1A binder
cabergoline,Alpha-2C adrenergic receptor agonist
cabergoline,Alpha-2C adrenergic receptor antagonist
cabergoline,Dopamine D5 receptor agonist
cabergoline,Dopamine D5 receptor antagonist
cabergoline,Dopamine D1 receptor agonist
cabergoline,Dopamine D1 receptor antagonist
cabergoline,5-hydroxytryptamine receptor 1B agonist
cabergoline,5-hydroxytryptamine receptor 1B antagonist
cabergoline,5-hydroxytryptamine receptor 2C agonist
cabergoline,5-hydroxytryptamine receptor 2C antagonist
cabergoline,5-hydroxytryptamine receptor 2C binder
cabergoline,5-hydroxytryptamine receptor 7 agonist
cabergoline,5-hydroxytryptamine receptor 7 antagonist
cabergoline,5-hydroxytryptamine receptor 7 binder
cabergoline,Alpha-1A adrenergic receptor agonist
cabergoline,Alpha-1A adrenergic receptor antagonist
cabergoline,Alpha-1A adrenergic receptor binder
cabergoline,Alpha-1B adrenergic receptor agonist
cabergoline,Alpha-1B adrenergic receptor antagonist
cabergoline,Alpha-1B adrenergic receptor binder
cabergoline,Alpha-1D adrenergic receptor agonist
cabergoline,Alpha-1D adrenergic receptor antagonist
cabergoline,Alpha-1D adrenergic receptor binder
cabergoline,Beta-1 adrenergic receptor agonist
cabergoline,Beta-1 adrenergic receptor antagonist
cabergoline,Beta-2 adrenergic receptor agonist
cabergoline,Beta-2 adrenergic receptor antagonist
cabergoline,D(1) dopamine receptor agonist
cabergoline,D(1) dopamine receptor antagonist
cabergoline,D(1) dopamine receptor binder
phenytoin,Sodium channel protein type 5 subunit alpha inhibitor
phenytoin,Nuclear receptor subfamily 1 group I member 2 inhibitor
phenytoin,Potassium voltage-gated channel subfamily H member 2 inhibitor
phenytoin,GABA(A) Receptor inhibitor
anagrelide,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A inhibitor"
metoprolol,Beta-1 adrenergic receptor antagonist
metoprolol,Beta-2 adrenergic receptor antagonist
ropinirole,Dopamine D3 receptor agonist
ropinirole,Dopamine D3 receptor antagonist
ropinirole,Dopamine D4 receptor agonist
ropinirole,Dopamine D4 receptor antagonist
ropinirole,Dopamine D2 receptor agonist
ropinirole,Dopamine D2 receptor antagonist
isradipine,Voltage-dependent L-type calcium channel subunit alpha-1C inhibitor
isradipine,Voltage-dependent calcium channel subunit alpha-2/delta-1 inhibitor
isradipine,Voltage-dependent L-type calcium channel subunit beta-2 inhibitor
isradipine,Voltage-dependent L-type calcium channel subunit alpha-1D inhibitor
isradipine,Voltage-dependent L-type calcium channel subunit alpha-1S inhibitor
topiramate,Gamma-aminobutyric acid receptor subunit alpha-1 agonist
topiramate,Gamma-aminobutyric acid receptor subunit alpha-1 antagonist
topiramate,Carbonic anhydrase 2 inhibitor
topiramate,Carbonic anhydrase 1 inhibitor
topiramate,Carbonic anhydrase 3 inhibitor
olmesartan,Type-1 angiotensin II receptor antagonist
amsacrine,DNA inhibitor
amsacrine,DNA topoisomerase 2-alpha inhibitor
amsacrine,Potassium voltage-gated channel subfamily H member 2 inhibitor
theophylline,Adenosine receptor A1 antagonist
theophylline,Adenosine receptor A1 inhibitor
theophylline,"cGMP-specific 3',5'-cyclic phosphodiesterase inhibitor"
theophylline,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A inhibitor"
theophylline,Histone deacetylase 2 inhibitor
disopyramide,Sodium channel protein type 5 subunit alpha inhibitor
disopyramide,Muscarinic acetylcholine receptor M1 inhibitor
disopyramide,Muscarinic acetylcholine receptor M1 antagonist
disopyramide,Muscarinic acetylcholine receptor M2 inhibitor
disopyramide,Muscarinic acetylcholine receptor M2 antagonist
disopyramide,Muscarinic acetylcholine receptor M3 inhibitor
disopyramide,Muscarinic acetylcholine receptor M3 antagonist
disopyramide,Potassium voltage-gated channel subfamily H member 2 inhibitor
disopyramide,Potassium voltage-gated channel subfamily H member 2 antagonist
lidocaine,Sodium channel protein type 10 subunit alpha inhibitor
lidocaine,Sodium channel protein type 5 subunit alpha inhibitor
clemastine,Histamine H1 receptor antagonist
venlafaxine,Sodium-dependent serotonin transporter inhibitor
venlafaxine,Sodium-dependent noradrenaline transporter inhibitor
venlafaxine,Sodium-dependent dopamine transporter inhibitor
atomoxetine,Sodium-dependent noradrenaline transporter inhibitor
atomoxetine,Sodium-dependent noradrenaline transporter binder
atomoxetine,Sodium-dependent serotonin transporter inhibitor
atomoxetine,Sodium-dependent serotonin transporter binder
atomoxetine,Kappa-type opioid receptor inhibitor
atomoxetine,Kappa-type opioid receptor binder
atomoxetine,Kappa-type opioid receptor partial agonist
bleomycin,DNA inhibitor
etomidate,Gamma-aminobutyric acid receptor subunit alpha-1 agonist
etomidate,Alpha-2B adrenergic receptor agonist
etomidate,GABA(A) Receptor agonist
raltitrexed,Thymidylate synthase inhibitor
morphine,Mu-type opioid receptor agonist
morphine,Kappa-type opioid receptor agonist
morphine,Delta-type opioid receptor agonist
ropivacaine,Sodium channel protein type 10 subunit alpha inhibitor
bupivacaine,Sodium channel protein type 10 subunit alpha inhibitor
penciclovir,DNA polymerase catalytic subunit inhibitor
ibutilide,Voltage-dependent L-type calcium channel subunit alpha-1C inhibitor
ibutilide,Potassium voltage-gated channel subfamily H member 2 inhibitor
ibutilide,Voltage-dependent calcium channel subunit alpha-2/delta-1 inhibitor
pentobarbital,Gamma-aminobutyric acid receptor subunit alpha-1 potentiator
pentobarbital,Gamma-aminobutyric acid receptor subunit alpha-1 antagonist
pentobarbital,Neuronal acetylcholine receptor subunit alpha-4 antagonist
pentobarbital,Neuronal acetylcholine receptor subunit alpha-7 antagonist
pentobarbital,GABA(A) Receptor antagonist
zolmitriptan,5-hydroxytryptamine receptor 1B agonist
zolmitriptan,5-hydroxytryptamine receptor 1D agonist
zolmitriptan,5-hydroxytryptamine receptor 1F agonist
zolmitriptan,5-hydroxytryptamine receptor 7 agonist
zolmitriptan,5-hydroxytryptamine receptor 1A agonist
zolmitriptan,5-hydroxytryptamine receptor 2A agonist
zolmitriptan,5-hydroxytryptamine receptor 2B agonist
acetaminophen,Prostaglandin G/H synthase 2 inhibitor
acetaminophen,Prostaglandin G/H synthase 1 inhibitor
codeine,Mu-type opioid receptor agonist
codeine,Kappa-type opioid receptor agonist
codeine,Delta-type opioid receptor agonist
dihydroergotamine,5-hydroxytryptamine receptor 1B agonist
dihydroergotamine,5-hydroxytryptamine receptor 1D agonist
dihydroergotamine,5-hydroxytryptamine receptor 1F agonist
dihydroergotamine,Alpha-2A adrenergic receptor agonist
dihydroergotamine,5-hydroxytryptamine receptor 1A agonist
dihydroergotamine,5-hydroxytryptamine receptor 2A agonist
dihydroergotamine,5-hydroxytryptamine receptor 2B agonist
dihydroergotamine,5-hydroxytryptamine receptor 2C agonist
dihydroergotamine,Alpha-1 adrenergic receptors agonist
dihydroergotamine,Alpha-2 adrenergic receptors agonist
dihydroergotamine,Dopamine D2 receptor agonist
dihydroergotamine,Dopamine D3 receptor agonist
dihydroergotamine,Dopamine D4 receptor agonist
dihydroergotamine,Beta-3 adrenergic receptor agonist
amitriptyline,Sodium-dependent noradrenaline transporter inhibitor
amitriptyline,Sodium-dependent noradrenaline transporter antagonist
amitriptyline,Sodium-dependent noradrenaline transporter agonist
amitriptyline,Sodium-dependent noradrenaline transporter binder
amitriptyline,Sodium-dependent serotonin transporter inhibitor
amitriptyline,Sodium-dependent serotonin transporter antagonist
amitriptyline,Sodium-dependent serotonin transporter agonist
amitriptyline,Sodium-dependent serotonin transporter binder
amitriptyline,5-hydroxytryptamine receptor 2A inhibitor
amitriptyline,5-hydroxytryptamine receptor 2A antagonist
amitriptyline,5-hydroxytryptamine receptor 2A agonist
amitriptyline,5-hydroxytryptamine receptor 2A binder
amitriptyline,5-hydroxytryptamine receptor 1A inhibitor
amitriptyline,5-hydroxytryptamine receptor 1A antagonist
amitriptyline,5-hydroxytryptamine receptor 1A agonist
amitriptyline,5-hydroxytryptamine receptor 1A binder
amitriptyline,Delta-type opioid receptor antagonist
amitriptyline,Delta-type opioid receptor agonist
amitriptyline,Kappa-type opioid receptor inhibitor
amitriptyline,Kappa-type opioid receptor antagonist
amitriptyline,Kappa-type opioid receptor agonist
amitriptyline,Kappa-type opioid receptor binder
amitriptyline,Alpha-1A adrenergic receptor inhibitor
amitriptyline,Alpha-1A adrenergic receptor antagonist
amitriptyline,Alpha-1A adrenergic receptor agonist
amitriptyline,Alpha-1A adrenergic receptor binder
amitriptyline,Alpha-1D adrenergic receptor inhibitor
amitriptyline,Alpha-1D adrenergic receptor antagonist
amitriptyline,Alpha-1D adrenergic receptor agonist
amitriptyline,Alpha-1D adrenergic receptor binder
amitriptyline,Alpha-2A adrenergic receptor inhibitor
amitriptyline,Alpha-2A adrenergic receptor antagonist
amitriptyline,Alpha-2A adrenergic receptor agonist
amitriptyline,Alpha-2A adrenergic receptor binder
amitriptyline,Histamine H1 receptor inhibitor
amitriptyline,Histamine H1 receptor antagonist
amitriptyline,Histamine H1 receptor agonist
amitriptyline,Histamine H1 receptor binder
amitriptyline,Histamine H2 receptor antagonist
amitriptyline,Histamine H4 receptor antagonist
amitriptyline,Histamine H4 receptor binder
amitriptyline,5-hydroxytryptamine receptor 2C inhibitor
amitriptyline,5-hydroxytryptamine receptor 2C antagonist
amitriptyline,5-hydroxytryptamine receptor 2C agonist
amitriptyline,5-hydroxytryptamine receptor 2C binder
amitriptyline,Alpha-1B adrenergic receptor inhibitor
amitriptyline,Alpha-1B adrenergic receptor antagonist
amitriptyline,Alpha-1B adrenergic receptor agonist
amitriptyline,Alpha-1B adrenergic receptor binder
amitriptyline,5-hydroxytryptamine receptor 7 inhibitor
amitriptyline,5-hydroxytryptamine receptor 7 antagonist
amitriptyline,5-hydroxytryptamine receptor 7 agonist
amitriptyline,5-hydroxytryptamine receptor 7 binder
amitriptyline,5-hydroxytryptamine receptor 1D antagonist
amitriptyline,5-hydroxytryptamine receptor 1D agonist
amitriptyline,Mu-type opioid receptor inhibitor
amitriptyline,Mu-type opioid receptor antagonist
amitriptyline,Mu-type opioid receptor agonist
amitriptyline,5-hydroxytryptamine receptor 1B antagonist
amitriptyline,5-hydroxytryptamine receptor 1B agonist
amitriptyline,5-hydroxytryptamine receptor 6 inhibitor
amitriptyline,5-hydroxytryptamine receptor 6 antagonist
amitriptyline,5-hydroxytryptamine receptor 6 binder
amitriptyline,Muscarinic acetylcholine receptor inhibitor
amitriptyline,Muscarinic acetylcholine receptor antagonist
amitriptyline,Muscarinic acetylcholine receptor binder
hydromorphone,Mu-type opioid receptor agonist
hydromorphone,Delta-type opioid receptor agonist
hydromorphone,Kappa-type opioid receptor agonist
hydromorphone,Kappa-type opioid receptor partial agonist
indomethacin,Prostaglandin G/H synthase 1 inhibitor
indomethacin,Prostaglandin G/H synthase 2 inhibitor
indomethacin,Peroxisome proliferator-activated receptor gamma inhibitor
indomethacin,Peroxisome proliferator-activated receptor gamma agonist
indomethacin,Peroxisome proliferator-activated receptor alpha inhibitor
indomethacin,Peroxisome proliferator-activated receptor alpha agonist
ipratropium,Muscarinic acetylcholine receptor M1 antagonist
ipratropium,Muscarinic acetylcholine receptor M2 antagonist
ipratropium,Muscarinic acetylcholine receptor M3 antagonist
methadone,Mu-type opioid receptor agonist
methadone,Mu-type opioid receptor antagonist
methadone,Delta-type opioid receptor agonist
methadone,Delta-type opioid receptor antagonist
methadone,5-hydroxytryptamine receptor 3A agonist
methadone,5-hydroxytryptamine receptor 3A antagonist
methadone,Neuronal acetylcholine receptor subunit alpha-7 antagonist
methadone,Neuronal acetylcholine receptor subunit alpha-4 agonist
methadone,Neuronal acetylcholine receptor subunit alpha-4 antagonist
olanzapine,5-hydroxytryptamine receptor 2A antagonist
olanzapine,5-hydroxytryptamine receptor 2A inhibitor
olanzapine,Dopamine D2 receptor antagonist
olanzapine,Dopamine D2 receptor inhibitor
olanzapine,Dopamine D1 receptor antagonist
olanzapine,Dopamine D1 receptor inhibitor
olanzapine,Dopamine D5 receptor antagonist
olanzapine,Dopamine D3 receptor antagonist
olanzapine,Dopamine D3 receptor inhibitor
olanzapine,Dopamine D4 receptor antagonist
olanzapine,5-hydroxytryptamine receptor 2C antagonist
olanzapine,5-hydroxytryptamine receptor 2C inhibitor
olanzapine,5-hydroxytryptamine receptor 3A antagonist
olanzapine,5-hydroxytryptamine receptor 3A inhibitor
olanzapine,5-hydroxytryptamine receptor 6 antagonist
olanzapine,5-hydroxytryptamine receptor 6 inhibitor
olanzapine,Histamine H1 receptor antagonist
olanzapine,Histamine H1 receptor inhibitor
olanzapine,Alpha-1A adrenergic receptor antagonist
olanzapine,Alpha-1A adrenergic receptor inhibitor
olanzapine,Alpha-1B adrenergic receptor antagonist
olanzapine,Alpha-1B adrenergic receptor inhibitor
olanzapine,Muscarinic acetylcholine receptor M1 antagonist
olanzapine,Muscarinic acetylcholine receptor M1 inhibitor
olanzapine,Muscarinic acetylcholine receptor M2 antagonist
olanzapine,Muscarinic acetylcholine receptor M2 inhibitor
olanzapine,Muscarinic acetylcholine receptor M3 antagonist
olanzapine,Muscarinic acetylcholine receptor M3 inhibitor
olanzapine,Muscarinic acetylcholine receptor M4 antagonist
olanzapine,Muscarinic acetylcholine receptor M4 inhibitor
olanzapine,D(1) dopamine receptor antagonist
olanzapine,D(1) dopamine receptor inhibitor
olanzapine,Beta adrenergic receptor inhibitor
atenolol,Beta-1 adrenergic receptor antagonist
atenolol,Beta-2 adrenergic receptor antagonist
cetirizine,Histamine H1 receptor antagonist
protriptyline,Sodium-dependent noradrenaline transporter inhibitor
protriptyline,Sodium-dependent serotonin transporter inhibitor
alfuzosin,Alpha-1A adrenergic receptor antagonist
alfuzosin,Alpha-1B adrenergic receptor antagonist
alfuzosin,Alpha-1D adrenergic receptor antagonist
alfuzosin,Alpha-1 adrenergic receptors antagonist
methylergometrine,Dopamine D1 receptor antagonist
methylergometrine,5-hydroxytryptamine receptor 2B antagonist
clozapine,Dopamine D2 receptor antagonist
clozapine,5-hydroxytryptamine receptor 2A antagonist
clozapine,Dopamine D1 receptor antagonist
clozapine,Dopamine D3 receptor antagonist
clozapine,Dopamine D4 receptor antagonist
clozapine,5-hydroxytryptamine receptor 1A antagonist
clozapine,5-hydroxytryptamine receptor 1B antagonist
clozapine,5-hydroxytryptamine receptor 1D antagonist
clozapine,5-hydroxytryptamine receptor 1E antagonist
clozapine,5-hydroxytryptamine receptor 3A antagonist
clozapine,5-hydroxytryptamine receptor 2C antagonist
clozapine,5-hydroxytryptamine receptor 6 antagonist
clozapine,5-hydroxytryptamine receptor 7 antagonist
clozapine,Histamine H1 receptor antagonist
clozapine,Histamine H4 receptor antagonist
clozapine,Alpha-1A adrenergic receptor antagonist
clozapine,Alpha-1B adrenergic receptor antagonist
clozapine,Alpha-2A adrenergic receptor antagonist
clozapine,Alpha-2B adrenergic receptor antagonist
clozapine,Alpha-2C adrenergic receptor antagonist
clozapine,Muscarinic acetylcholine receptor M1 antagonist
clozapine,Muscarinic acetylcholine receptor M2 antagonist
clozapine,Muscarinic acetylcholine receptor M3 antagonist
clozapine,Muscarinic acetylcholine receptor M4 antagonist
clozapine,Muscarinic acetylcholine receptor M5 antagonist
levonorgestrel,Estrogen receptor alpha inhibitor
levonorgestrel,Androgen receptor inhibitor
norepinephrine,Alpha-1A adrenergic receptor agonist
norepinephrine,Alpha-1A adrenergic receptor inhibitor
norepinephrine,Alpha-1A adrenergic receptor binder
norepinephrine,Alpha-1B adrenergic receptor agonist
norepinephrine,Alpha-1B adrenergic receptor inhibitor
norepinephrine,Alpha-1B adrenergic receptor binder
norepinephrine,Alpha-1D adrenergic receptor agonist
norepinephrine,Alpha-1D adrenergic receptor inhibitor
norepinephrine,Alpha-1D adrenergic receptor binder
norepinephrine,Alpha-2A adrenergic receptor agonist
norepinephrine,Alpha-2A adrenergic receptor inhibitor
norepinephrine,Alpha-2A adrenergic receptor binder
norepinephrine,Alpha-2B adrenergic receptor agonist
norepinephrine,Alpha-2B adrenergic receptor inhibitor
norepinephrine,Alpha-2B adrenergic receptor binder
norepinephrine,Alpha-2C adrenergic receptor agonist
norepinephrine,Alpha-2C adrenergic receptor inhibitor
norepinephrine,Beta-1 adrenergic receptor agonist
norepinephrine,Beta-1 adrenergic receptor inhibitor
norepinephrine,Beta-2 adrenergic receptor agonist
norepinephrine,Beta-2 adrenergic receptor inhibitor
norepinephrine,Beta-3 adrenergic receptor agonist
norepinephrine,Synaptic vesicular amine transporter inhibitor
cidofovir,DNA polymerase catalytic subunit inhibitor
mirtazapine,5-hydroxytryptamine receptor 2A antagonist
mirtazapine,5-hydroxytryptamine receptor 2A agonist
mirtazapine,Alpha-2A adrenergic receptor antagonist
mirtazapine,Alpha-2A adrenergic receptor agonist
mirtazapine,5-hydroxytryptamine receptor 2C antagonist
mirtazapine,5-hydroxytryptamine receptor 2C agonist
mirtazapine,Kappa-type opioid receptor antagonist
mirtazapine,Kappa-type opioid receptor agonist
mirtazapine,Histamine H1 receptor antagonist
mirtazapine,Histamine H1 receptor agonist
mirtazapine,Alpha-1 adrenergic receptors antagonist
mirtazapine,Alpha-1 adrenergic receptors agonist
meprobamate,Gamma-aminobutyric acid receptor subunit alpha-1 agonist
meprobamate,GABA(A) Receptor agonist
timolol,Beta-1 adrenergic receptor antagonist
timolol,Beta-2 adrenergic receptor antagonist
trihexyphenidyl,Muscarinic acetylcholine receptor M1 antagonist
trihexyphenidyl,Muscarinic acetylcholine receptor M2 antagonist
trihexyphenidyl,Muscarinic acetylcholine receptor M3 antagonist
trihexyphenidyl,Muscarinic acetylcholine receptor M4 antagonist
trihexyphenidyl,Muscarinic acetylcholine receptor M5 antagonist
palonosetron,5-hydroxytryptamine receptor 3A antagonist
mexiletine,Sodium channel protein type 5 subunit alpha inhibitor
dexrazoxane,DNA topoisomerase 2-alpha inhibitor
amlodipine,Voltage-dependent L-type calcium channel subunit alpha-1C inhibitor
amlodipine,Carbonic anhydrase 1 inhibitor
phenylephrine,Alpha-1A adrenergic receptor agonist
phenylephrine,Alpha-1B adrenergic receptor agonist
phenylephrine,Alpha-1D adrenergic receptor agonist
nimodipine,Voltage-dependent L-type calcium channel subunit alpha-1C inhibitor
nimodipine,Voltage-dependent L-type calcium channel subunit alpha-1D inhibitor
nimodipine,Voltage-dependent L-type calcium channel subunit alpha-1S inhibitor
nimodipine,Voltage-dependent L-type calcium channel subunit beta-2 inhibitor
progesterone,Estrogen receptor alpha agonist
progesterone,Estrogen receptor alpha inhibitor
progesterone,Estrogen receptor alpha antagonist
progesterone,Kappa-type opioid receptor agonist
progesterone,Kappa-type opioid receptor inhibitor
progesterone,Kappa-type opioid receptor antagonist
progesterone,Kappa-type opioid receptor binder
progesterone,Kappa-type opioid receptor partial agonist
progesterone,Glucocorticoid receptor agonist
progesterone,Androgen receptor agonist
progesterone,Androgen receptor inhibitor
progesterone,Androgen receptor antagonist
progesterone,Estrogen receptor beta agonist
phenylpropanolamine,Dopamine D1 receptor agonist
phenylpropanolamine,Beta-1 adrenergic receptor partial agonist
phenylpropanolamine,Beta-1 adrenergic receptor agonist
phenylpropanolamine,Beta-2 adrenergic receptor partial agonist
phenylpropanolamine,Beta-2 adrenergic receptor agonist
phenylpropanolamine,Alpha-2 adrenergic receptors agonist
sorafenib,Vascular endothelial growth factor receptor 2 inhibitor
sorafenib,Platelet-derived growth factor receptor beta inhibitor
sorafenib,Mast/stem cell growth factor receptor Kit inhibitor
nisoldipine,Voltage-dependent L-type calcium channel subunit alpha-1C inhibitor
nisoldipine,Voltage-dependent calcium channel subunit alpha-2/delta-1 inhibitor
nisoldipine,Voltage-dependent L-type calcium channel subunit beta-2 inhibitor
nisoldipine,Voltage-dependent L-type calcium channel subunit alpha-1D inhibitor
nisoldipine,Voltage-dependent L-type calcium channel subunit alpha-1S inhibitor
alprazolam,GABA(A) Receptor ligand
alprazolam,GABA(A) Receptor Benzodiazepine Binding Site ligand
loxapine,Dopamine D2 receptor antagonist
loxapine,Dopamine D2 receptor binder
loxapine,Dopamine D1 receptor antagonist
loxapine,5-hydroxytryptamine receptor 2A antagonist
loxapine,5-hydroxytryptamine receptor 2A binder
loxapine,5-hydroxytryptamine receptor 2C antagonist
loxapine,5-hydroxytryptamine receptor 2C binder
loxapine,5-hydroxytryptamine receptor 1A antagonist
loxapine,5-hydroxytryptamine receptor 1A binder
loxapine,5-hydroxytryptamine receptor 1B antagonist
loxapine,5-hydroxytryptamine receptor 1D antagonist
loxapine,5-hydroxytryptamine receptor 1E antagonist
loxapine,5-hydroxytryptamine receptor 3A antagonist
loxapine,5-hydroxytryptamine receptor 3A binder
loxapine,5-hydroxytryptamine receptor 6 antagonist
loxapine,5-hydroxytryptamine receptor 6 binder
loxapine,5-hydroxytryptamine receptor 7 antagonist
loxapine,5-hydroxytryptamine receptor 7 binder
loxapine,Alpha-1A adrenergic receptor antagonist
loxapine,Alpha-1A adrenergic receptor binder
loxapine,Alpha-1B adrenergic receptor antagonist
loxapine,Alpha-1B adrenergic receptor binder
loxapine,Alpha-2A adrenergic receptor antagonist
loxapine,Alpha-2A adrenergic receptor binder
loxapine,Alpha-2B adrenergic receptor antagonist
loxapine,Alpha-2B adrenergic receptor binder
loxapine,Alpha-2C adrenergic receptor antagonist
loxapine,Beta-1 adrenergic receptor antagonist
loxapine,Muscarinic acetylcholine receptor M1 antagonist
loxapine,Muscarinic acetylcholine receptor M1 binder
loxapine,Muscarinic acetylcholine receptor M2 antagonist
loxapine,Muscarinic acetylcholine receptor M3 antagonist
loxapine,Muscarinic acetylcholine receptor M3 binder
loxapine,Muscarinic acetylcholine receptor M4 antagonist
loxapine,Muscarinic acetylcholine receptor M5 antagonist
loxapine,D(1) dopamine receptor antagonist
loxapine,D(1) dopamine receptor binder
loxapine,Dopamine D3 receptor antagonist
loxapine,Dopamine D3 receptor binder
loxapine,Dopamine D4 receptor antagonist
loxapine,Dopamine D5 receptor antagonist
loxapine,Histamine H1 receptor antagonist
loxapine,Histamine H1 receptor binder
loxapine,Histamine H2 receptor antagonist
loxapine,Histamine H4 receptor antagonist
loxapine,Histamine H4 receptor binder
loxapine,Sodium-dependent serotonin transporter antagonist
loxapine,Sodium-dependent serotonin transporter binder
loxapine,Sodium-dependent noradrenaline transporter antagonist
loxapine,Sodium-dependent noradrenaline transporter binder
loxapine,Sodium-dependent dopamine transporter antagonist
loxapine,Sodium-dependent dopamine transporter binder
rosiglitazone,Peroxisome proliferator-activated receptor gamma agonist
rosiglitazone,Peroxisome proliferator-activated receptor gamma inhibitor
rosiglitazone,Peroxisome proliferator-activated receptor alpha agonist
rosiglitazone,Peroxisome proliferator-activated receptor alpha inhibitor
pramipexole,Dopamine D3 receptor agonist
pramipexole,Dopamine D2 receptor agonist
pramipexole,Dopamine D4 receptor agonist
pramipexole,5-hydroxytryptamine receptor 1A agonist
pramipexole,Alpha-2A adrenergic receptor agonist
secobarbital,Gamma-aminobutyric acid receptor subunit alpha-1 potentiator
secobarbital,Gamma-aminobutyric acid receptor subunit alpha-1 antagonist
secobarbital,Neuronal acetylcholine receptor subunit alpha-4 antagonist
secobarbital,Neuronal acetylcholine receptor subunit alpha-7 antagonist
methylphenidate,Sodium-dependent dopamine transporter inhibitor
methylphenidate,Sodium-dependent noradrenaline transporter inhibitor
methylphenidate,5-hydroxytryptamine receptor 1A inhibitor
methocarbamol,Carbonic anhydrase 1 inhibitor
zolpidem,Gamma-aminobutyric acid receptor subunit alpha-1 agonist
famciclovir,DNA polymerase catalytic subunit inhibitor
prochlorperazine,Dopamine D2 receptor antagonist
prochlorperazine,Histamine H1 receptor antagonist
prochlorperazine,Alpha-1 adrenergic receptors antagonist
prochlorperazine,Alpha-2 adrenergic receptors antagonist
cyproheptadine,Histamine H1 receptor antagonist
cyproheptadine,Histamine H2 receptor antagonist
cyproheptadine,5-hydroxytryptamine receptor 2A antagonist
cyproheptadine,5-hydroxytryptamine receptor 2B antagonist
cyproheptadine,5-hydroxytryptamine receptor 2C antagonist
cyproheptadine,Muscarinic acetylcholine receptor M1 antagonist
cyproheptadine,Muscarinic acetylcholine receptor M2 antagonist
cyproheptadine,Muscarinic acetylcholine receptor M3 antagonist
cyproheptadine,5-hydroxytryptamine receptor 7 antagonist
gemcitabine,DNA inhibitor
gemcitabine,Thymidylate synthase inhibitor
teniposide,DNA topoisomerase 2-alpha inhibitor
dipivefrin,Alpha-1A adrenergic receptor agonist
dipivefrin,Alpha-1A adrenergic receptor inhibitor
dipivefrin,Alpha-2A adrenergic receptor agonist
dipivefrin,Alpha-2A adrenergic receptor inhibitor
dipivefrin,Beta-2 adrenergic receptor agonist
dipivefrin,Beta-2 adrenergic receptor inhibitor
dipivefrin,Cholinesterase inhibitor
dipivefrin,Acetylcholinesterase inhibitor
droperidol,Dopamine D2 receptor antagonist
droperidol,Alpha-1A adrenergic receptor antagonist
meperidine,Kappa-type opioid receptor antagonist
meperidine,Kappa-type opioid receptor binder
meperidine,Kappa-type opioid receptor agonist
meperidine,Kappa-type opioid receptor inhibitor
meperidine,Muscarinic acetylcholine receptor antagonist
meperidine,Muscarinic acetylcholine receptor binder
meperidine,Muscarinic acetylcholine receptor inhibitor
meperidine,Mu-type opioid receptor antagonist
meperidine,Mu-type opioid receptor agonist
meperidine,Mu-type opioid receptor inhibitor
meperidine,Sodium-dependent dopamine transporter antagonist
meperidine,Sodium-dependent dopamine transporter binder
meperidine,Sodium-dependent dopamine transporter agonist
meperidine,Sodium-dependent dopamine transporter inhibitor
meperidine,Sodium-dependent noradrenaline transporter antagonist
meperidine,Sodium-dependent noradrenaline transporter binder
meperidine,Sodium-dependent noradrenaline transporter agonist
meperidine,Sodium-dependent noradrenaline transporter inhibitor
meperidine,Sodium-dependent serotonin transporter antagonist
meperidine,Sodium-dependent serotonin transporter binder
meperidine,Sodium-dependent serotonin transporter agonist
meperidine,Sodium-dependent serotonin transporter inhibitor
loratadine,Histamine H1 receptor antagonist
loratadine,Potassium voltage-gated channel subfamily H member 2 antagonist
prazosin,Alpha-1A adrenergic receptor antagonist
prazosin,Alpha-1A adrenergic receptor inhibitor
prazosin,Alpha-1A adrenergic receptor binder
prazosin,Alpha-1B adrenergic receptor antagonist
prazosin,Alpha-1B adrenergic receptor inhibitor
prazosin,Alpha-1B adrenergic receptor binder
prazosin,Alpha-1D adrenergic receptor antagonist
prazosin,Alpha-1D adrenergic receptor inhibitor
prazosin,Alpha-1D adrenergic receptor binder
prazosin,Potassium voltage-gated channel subfamily H member 2 antagonist
prazosin,Potassium voltage-gated channel subfamily H member 2 inhibitor
prazosin,Potassium voltage-gated channel subfamily H member 2 binder
prazosin,Alpha-2A adrenergic receptor antagonist
prazosin,Alpha-2A adrenergic receptor inhibitor
prazosin,Alpha-2A adrenergic receptor binder
prazosin,Alpha-2B adrenergic receptor antagonist
prazosin,Alpha-2B adrenergic receptor inhibitor
prazosin,Alpha-2B adrenergic receptor binder
prazosin,Alpha-1 adrenergic receptors antagonist
prazosin,Alpha-1 adrenergic receptors inhibitor
prazosin,Alpha-1 adrenergic receptors binder
imipramine,Sodium-dependent noradrenaline transporter inhibitor
imipramine,Sodium-dependent noradrenaline transporter antagonist
imipramine,Sodium-dependent noradrenaline transporter binder
imipramine,5-hydroxytryptamine receptor 2A inhibitor
imipramine,5-hydroxytryptamine receptor 2A antagonist
imipramine,5-hydroxytryptamine receptor 2A binder
imipramine,Sodium-dependent serotonin transporter inhibitor
imipramine,Sodium-dependent serotonin transporter antagonist
imipramine,Sodium-dependent serotonin transporter binder
imipramine,Histamine H1 receptor inhibitor
imipramine,Histamine H1 receptor antagonist
imipramine,Histamine H1 receptor binder
imipramine,Alpha-1A adrenergic receptor inhibitor
imipramine,Alpha-1A adrenergic receptor antagonist
imipramine,Alpha-1A adrenergic receptor binder
imipramine,Alpha-1D adrenergic receptor inhibitor
imipramine,Alpha-1D adrenergic receptor antagonist
imipramine,Alpha-1D adrenergic receptor binder
imipramine,Muscarinic acetylcholine receptor M1 inhibitor
imipramine,Muscarinic acetylcholine receptor M1 antagonist
imipramine,Muscarinic acetylcholine receptor M1 binder
imipramine,Muscarinic acetylcholine receptor M2 inhibitor
imipramine,Muscarinic acetylcholine receptor M2 antagonist
imipramine,Muscarinic acetylcholine receptor M3 inhibitor
imipramine,Muscarinic acetylcholine receptor M3 antagonist
imipramine,Muscarinic acetylcholine receptor M3 binder
imipramine,Muscarinic acetylcholine receptor M4 inhibitor
imipramine,Muscarinic acetylcholine receptor M4 antagonist
imipramine,Muscarinic acetylcholine receptor M5 inhibitor
imipramine,Muscarinic acetylcholine receptor M5 antagonist
imipramine,5-hydroxytryptamine receptor 2C inhibitor
imipramine,5-hydroxytryptamine receptor 2C antagonist
imipramine,5-hydroxytryptamine receptor 2C binder
imipramine,Alpha-1B adrenergic receptor inhibitor
imipramine,Alpha-1B adrenergic receptor antagonist
imipramine,Alpha-1B adrenergic receptor binder
imipramine,5-hydroxytryptamine receptor 7 inhibitor
imipramine,5-hydroxytryptamine receptor 7 antagonist
imipramine,5-hydroxytryptamine receptor 7 binder
imipramine,D(1) dopamine receptor inhibitor
imipramine,D(1) dopamine receptor antagonist
imipramine,D(1) dopamine receptor binder
imipramine,Dopamine D2 receptor inhibitor
imipramine,Dopamine D2 receptor antagonist
imipramine,Dopamine D2 receptor binder
imipramine,Potassium voltage-gated channel subfamily H member 2 inhibitor
imipramine,Potassium voltage-gated channel subfamily H member 2 antagonist
imipramine,Potassium voltage-gated channel subfamily H member 2 binder
imipramine,Sodium-dependent dopamine transporter inhibitor
imipramine,Sodium-dependent dopamine transporter antagonist
imipramine,Sodium-dependent dopamine transporter binder
imipramine,5-hydroxytryptamine receptor 1A inhibitor
imipramine,5-hydroxytryptamine receptor 1A antagonist
imipramine,5-hydroxytryptamine receptor 1A binder
imipramine,5-hydroxytryptamine receptor 6 inhibitor
imipramine,5-hydroxytryptamine receptor 6 antagonist
imipramine,5-hydroxytryptamine receptor 6 binder
nabumetone,Prostaglandin G/H synthase 2 inhibitor
nabumetone,Prostaglandin G/H synthase 1 inhibitor
ketorolac,Prostaglandin G/H synthase 2 inhibitor
ketorolac,Prostaglandin G/H synthase 1 inhibitor
tenoxicam,Prostaglandin G/H synthase 2 inhibitor
tenoxicam,Prostaglandin G/H synthase 1 inhibitor
fluoxetine,Sodium-dependent serotonin transporter inhibitor
fluoxetine,Sodium-dependent serotonin transporter antagonist
fluoxetine,5-hydroxytryptamine receptor 2C inhibitor
fluoxetine,5-hydroxytryptamine receptor 2C antagonist
fluoxetine,Neuronal acetylcholine receptor subunit alpha-2 antagonist
fluoxetine,Potassium voltage-gated channel subfamily H member 2 inhibitor
fluoxetine,Potassium voltage-gated channel subfamily H member 2 antagonist
methohexital,Gamma-aminobutyric acid receptor subunit alpha-1 antagonist
duloxetine,Sodium-dependent serotonin transporter inhibitor
duloxetine,Sodium-dependent noradrenaline transporter inhibitor
duloxetine,Sodium-dependent dopamine transporter inhibitor
chlorpromazine,Dopamine D2 receptor antagonist
chlorpromazine,Dopamine D2 receptor inhibitor
chlorpromazine,Dopamine D2 receptor binder
chlorpromazine,Dopamine D1 receptor antagonist
chlorpromazine,Dopamine D1 receptor inhibitor
chlorpromazine,5-hydroxytryptamine receptor 1A antagonist
chlorpromazine,5-hydroxytryptamine receptor 1A inhibitor
chlorpromazine,5-hydroxytryptamine receptor 1A binder
chlorpromazine,5-hydroxytryptamine receptor 2A antagonist
chlorpromazine,5-hydroxytryptamine receptor 2A inhibitor
chlorpromazine,5-hydroxytryptamine receptor 2A binder
chlorpromazine,Alpha-1A adrenergic receptor antagonist
chlorpromazine,Alpha-1A adrenergic receptor inhibitor
chlorpromazine,Alpha-1A adrenergic receptor binder
chlorpromazine,Alpha-1B adrenergic receptor antagonist
chlorpromazine,Alpha-1B adrenergic receptor inhibitor
chlorpromazine,Alpha-1B adrenergic receptor binder
chlorpromazine,Histamine H1 receptor antagonist
chlorpromazine,Histamine H1 receptor inhibitor
chlorpromazine,Histamine H1 receptor binder
chlorpromazine,Potassium voltage-gated channel subfamily H member 2 antagonist
chlorpromazine,Potassium voltage-gated channel subfamily H member 2 inhibitor
chlorpromazine,Potassium voltage-gated channel subfamily H member 2 binder
chlorpromazine,D(1) dopamine receptor antagonist
chlorpromazine,D(1) dopamine receptor inhibitor
chlorpromazine,D(1) dopamine receptor binder
chlorpromazine,Dopamine D3 receptor antagonist
chlorpromazine,Dopamine D3 receptor inhibitor
chlorpromazine,Dopamine D3 receptor binder
chlorpromazine,Dopamine D4 receptor antagonist
chlorpromazine,Dopamine D5 receptor antagonist
chlorpromazine,5-hydroxytryptamine receptor 2C antagonist
chlorpromazine,5-hydroxytryptamine receptor 2C inhibitor
chlorpromazine,5-hydroxytryptamine receptor 2C binder
chlorpromazine,Alpha-1 adrenergic receptors antagonist
chlorpromazine,Alpha-1 adrenergic receptors inhibitor
chlorpromazine,Alpha-1 adrenergic receptors binder
chlorpromazine,Alpha-2 adrenergic receptors antagonist
chlorpromazine,Alpha-2 adrenergic receptors inhibitor
chlorpromazine,Alpha-2 adrenergic receptors binder
chlorpromazine,Muscarinic acetylcholine receptor M1 antagonist
chlorpromazine,Muscarinic acetylcholine receptor M1 inhibitor
chlorpromazine,Muscarinic acetylcholine receptor M1 binder
chlorpromazine,Muscarinic acetylcholine receptor M3 antagonist
chlorpromazine,Muscarinic acetylcholine receptor M3 inhibitor
chlorpromazine,Muscarinic acetylcholine receptor M3 binder
chlorpromazine,Calmodulin antagonist
chlorpromazine,Calmodulin inhibitor
chlorpromazine,5-hydroxytryptamine receptor 6 antagonist
chlorpromazine,5-hydroxytryptamine receptor 6 inhibitor
chlorpromazine,5-hydroxytryptamine receptor 6 binder
chlorpromazine,5-hydroxytryptamine receptor 7 antagonist
chlorpromazine,5-hydroxytryptamine receptor 7 inhibitor
chlorpromazine,5-hydroxytryptamine receptor 7 binder
chlorpromazine,Histamine H4 receptor antagonist
chlorpromazine,Histamine H4 receptor binder
lenalidomide,Prostaglandin G/H synthase 2 inhibitor
raloxifene,Estrogen receptor alpha agonist
raloxifene,Estrogen receptor beta agonist
celecoxib,Prostaglandin G/H synthase 2 inhibitor
celecoxib,Carbonic anhydrase 2 inhibitor
celecoxib,Carbonic anhydrase 3 inhibitor
brimonidine,Alpha-2A adrenergic receptor agonist
brimonidine,Alpha-2B adrenergic receptor agonist
brimonidine,Alpha-2C adrenergic receptor agonist
sotalol,Potassium voltage-gated channel subfamily H member 2 inhibitor
sotalol,Potassium voltage-gated channel subfamily H member 2 antagonist
sotalol,Beta-1 adrenergic receptor inhibitor
sotalol,Beta-1 adrenergic receptor antagonist
sotalol,Beta-2 adrenergic receptor inhibitor
sotalol,Beta-2 adrenergic receptor antagonist
buspirone,5-hydroxytryptamine receptor 1A partial agonist
buspirone,5-hydroxytryptamine receptor 1A antagonist
buspirone,Dopamine D2 receptor antagonist
buspirone,Dopamine D3 receptor antagonist
buspirone,Dopamine D4 receptor antagonist
buspirone,Alpha-1 adrenergic receptors antagonist
fosinopril,Angiotensin-converting enzyme inhibitor
zidovudine,Reverse transcriptase/RNaseH inhibitor
darifenacin,Muscarinic acetylcholine receptor M3 antagonist
darifenacin,Muscarinic acetylcholine receptor M1 antagonist
darifenacin,Muscarinic acetylcholine receptor M2 antagonist
darifenacin,Muscarinic acetylcholine receptor M4 antagonist
darifenacin,Muscarinic acetylcholine receptor M5 antagonist
oxycodone,Mu-type opioid receptor agonist
oxycodone,Kappa-type opioid receptor agonist
oxycodone,Delta-type opioid receptor agonist
tolmetin,Prostaglandin G/H synthase 2 inhibitor
tolmetin,Prostaglandin G/H synthase 1 inhibitor
cimetidine,Histamine H2 receptor antagonist
haloperidol,Dopamine D2 receptor antagonist
haloperidol,Dopamine D2 receptor other/unknown
haloperidol,Dopamine D1 receptor antagonist
haloperidol,5-hydroxytryptamine receptor 2A antagonist
haloperidol,5-hydroxytryptamine receptor 2A other/unknown
haloperidol,Dopamine D3 receptor antagonist
haloperidol,5-hydroxytryptamine receptor 2C antagonist
haloperidol,Histamine H1 receptor antagonist
haloperidol,Muscarinic acetylcholine receptor M3 antagonist
haloperidol,Alpha-1A adrenergic receptor antagonist
haloperidol,Alpha-2A adrenergic receptor antagonist
haloperidol,Alpha-2B adrenergic receptor antagonist
haloperidol,Alpha-2C adrenergic receptor antagonist
haloperidol,5-hydroxytryptamine receptor 1A antagonist
haloperidol,5-hydroxytryptamine receptor 1A other/unknown
haloperidol,5-hydroxytryptamine receptor 6 antagonist
haloperidol,5-hydroxytryptamine receptor 7 antagonist
ritonavir,Human immunodeficiency virus type 1 protease inhibitor
ritonavir,Nuclear receptor subfamily 1 group I member 2 inhibitor
trandolapril,Angiotensin-converting enzyme inhibitor
carteolol,Beta-2 adrenergic receptor antagonist
carteolol,Beta-2 adrenergic receptor partial agonist
carteolol,Beta-1 adrenergic receptor antagonist
carteolol,Beta-1 adrenergic receptor partial agonist
foscarnet,DNA polymerase catalytic subunit inhibitor
foscarnet,DNA polymerase catalytic subunit inhibitor
erlotinib,Nuclear receptor subfamily 1 group I member 2 agonist
rofecoxib,Prostaglandin G/H synthase 2 inhibitor
ciprofloxacin,DNA topoisomerase 4 subunit A inhibitor
ciprofloxacin,DNA gyrase subunit A inhibitor
ciprofloxacin,DNA topoisomerase 2-alpha inhibitor
ciprofloxacin,Potassium voltage-gated channel subfamily H member 2 inhibitor
ciprofloxacin,DNA gyrase subunit A inhibitor
ciprofloxacin,DNA topoisomerase 4 subunit A inhibitor
ciprofloxacin,DNA gyrase subunit A inhibitor
ciprofloxacin,DNA gyrase subunit A inhibitor
nortriptyline,Sodium-dependent noradrenaline transporter inhibitor
nortriptyline,Sodium-dependent noradrenaline transporter antagonist
nortriptyline,Sodium-dependent noradrenaline transporter binder
nortriptyline,Sodium-dependent serotonin transporter inhibitor
nortriptyline,Sodium-dependent serotonin transporter antagonist
nortriptyline,Sodium-dependent serotonin transporter binder
nortriptyline,5-hydroxytryptamine receptor 2A inhibitor
nortriptyline,5-hydroxytryptamine receptor 2A antagonist
nortriptyline,5-hydroxytryptamine receptor 2A binder
nortriptyline,5-hydroxytryptamine receptor 1A inhibitor
nortriptyline,5-hydroxytryptamine receptor 1A antagonist
nortriptyline,5-hydroxytryptamine receptor 1A binder
nortriptyline,Histamine H1 receptor inhibitor
nortriptyline,Histamine H1 receptor antagonist
nortriptyline,Histamine H1 receptor binder
nortriptyline,Alpha-1A adrenergic receptor inhibitor
nortriptyline,Alpha-1A adrenergic receptor antagonist
nortriptyline,Alpha-1A adrenergic receptor binder
nortriptyline,Alpha-1D adrenergic receptor inhibitor
nortriptyline,Alpha-1D adrenergic receptor antagonist
nortriptyline,Alpha-1D adrenergic receptor binder
nortriptyline,5-hydroxytryptamine receptor 2C inhibitor
nortriptyline,5-hydroxytryptamine receptor 2C antagonist
nortriptyline,5-hydroxytryptamine receptor 2C binder
nortriptyline,Alpha-1B adrenergic receptor inhibitor
nortriptyline,Alpha-1B adrenergic receptor antagonist
nortriptyline,Alpha-1B adrenergic receptor binder
nortriptyline,Alpha-2 adrenergic receptors inhibitor
nortriptyline,Alpha-2 adrenergic receptors antagonist
nortriptyline,Alpha-2 adrenergic receptors binder
nortriptyline,Beta adrenergic receptor inhibitor
nortriptyline,Dopamine D2 receptor inhibitor
nortriptyline,Dopamine D2 receptor antagonist
nortriptyline,Dopamine D2 receptor binder
nortriptyline,Muscarinic acetylcholine receptor inhibitor
nortriptyline,Muscarinic acetylcholine receptor antagonist
nortriptyline,Muscarinic acetylcholine receptor binder
benazepril,Angiotensin-converting enzyme inhibitor
amoxapine,Sodium-dependent noradrenaline transporter inhibitor
amoxapine,Sodium-dependent noradrenaline transporter antagonist
amoxapine,Sodium-dependent noradrenaline transporter binder
amoxapine,Sodium-dependent serotonin transporter inhibitor
amoxapine,Sodium-dependent serotonin transporter antagonist
amoxapine,Sodium-dependent serotonin transporter binder
amoxapine,Dopamine D2 receptor inhibitor
amoxapine,Dopamine D2 receptor antagonist
amoxapine,Dopamine D2 receptor binder
amoxapine,Dopamine D1 receptor inhibitor
amoxapine,Dopamine D1 receptor antagonist
amoxapine,Alpha-2A adrenergic receptor inhibitor
amoxapine,Alpha-2A adrenergic receptor antagonist
amoxapine,Alpha-2A adrenergic receptor binder
amoxapine,Alpha-1A adrenergic receptor inhibitor
amoxapine,Alpha-1A adrenergic receptor antagonist
amoxapine,Alpha-1A adrenergic receptor binder
amoxapine,Muscarinic acetylcholine receptor M1 inhibitor
amoxapine,Muscarinic acetylcholine receptor M1 antagonist
amoxapine,Muscarinic acetylcholine receptor M1 binder
amoxapine,Gamma-aminobutyric acid receptor subunit alpha-1 antagonist
amoxapine,5-hydroxytryptamine receptor 2A inhibitor
amoxapine,5-hydroxytryptamine receptor 2A antagonist
amoxapine,5-hydroxytryptamine receptor 2A binder
amoxapine,5-hydroxytryptamine receptor 2C inhibitor
amoxapine,5-hydroxytryptamine receptor 2C antagonist
amoxapine,5-hydroxytryptamine receptor 2C binder
amoxapine,5-hydroxytryptamine receptor 6 inhibitor
amoxapine,5-hydroxytryptamine receptor 6 antagonist
amoxapine,5-hydroxytryptamine receptor 6 binder
amoxapine,5-hydroxytryptamine receptor 7 inhibitor
amoxapine,5-hydroxytryptamine receptor 7 antagonist
amoxapine,5-hydroxytryptamine receptor 7 binder
amoxapine,Dopamine D3 receptor inhibitor
amoxapine,Dopamine D3 receptor antagonist
amoxapine,Dopamine D3 receptor binder
amoxapine,Dopamine D4 receptor antagonist
amoxapine,Histamine H1 receptor inhibitor
amoxapine,Histamine H1 receptor antagonist
amoxapine,Histamine H1 receptor binder
amoxapine,Alpha-1 adrenergic receptors inhibitor
amoxapine,Alpha-1 adrenergic receptors antagonist
amoxapine,Alpha-1 adrenergic receptors binder
amoxapine,Muscarinic acetylcholine receptor inhibitor
amoxapine,Muscarinic acetylcholine receptor antagonist
amoxapine,Muscarinic acetylcholine receptor binder
amoxapine,5-hydroxytryptamine receptor 2B inhibitor
amoxapine,5-hydroxytryptamine receptor 2B antagonist
amoxapine,5-hydroxytryptamine receptor 2B binder
amoxapine,5-hydroxytryptamine receptor 3A inhibitor
amoxapine,5-hydroxytryptamine receptor 3A antagonist
amoxapine,5-hydroxytryptamine receptor 3A binder
amoxapine,5-hydroxytryptamine receptor 1A inhibitor
amoxapine,5-hydroxytryptamine receptor 1A antagonist
amoxapine,5-hydroxytryptamine receptor 1A binder
amoxapine,5-hydroxytryptamine receptor 1B antagonist
amoxapine,Alpha-2 adrenergic receptors inhibitor
amoxapine,Alpha-2 adrenergic receptors antagonist
amoxapine,Alpha-2 adrenergic receptors binder
amoxapine,Histamine H4 receptor antagonist
amoxapine,Histamine H4 receptor binder
amoxapine,GABA(A) Receptor inhibitor
amoxapine,GABA(A) Receptor antagonist
amoxapine,Sodium-dependent dopamine transporter inhibitor
amoxapine,Sodium-dependent dopamine transporter antagonist
amoxapine,Sodium-dependent dopamine transporter binder
pyridostigmine,Acetylcholinesterase inhibitor
pyridostigmine,Cholinesterase inhibitor
piroxicam,Prostaglandin G/H synthase 2 inhibitor
piroxicam,Prostaglandin G/H synthase 1 inhibitor
lamotrigine,Adenosine receptor A1 inhibitor
lamotrigine,Adenosine receptor A1 antagonist
lamotrigine,Alpha-1A adrenergic receptor inhibitor
lamotrigine,Alpha-1A adrenergic receptor agonist
lamotrigine,Alpha-1A adrenergic receptor antagonist
lamotrigine,Alpha-2A adrenergic receptor inhibitor
lamotrigine,Alpha-2A adrenergic receptor agonist
lamotrigine,Alpha-2A adrenergic receptor antagonist
lamotrigine,Beta-1 adrenergic receptor inhibitor
lamotrigine,Beta-1 adrenergic receptor agonist
lamotrigine,Beta-1 adrenergic receptor antagonist
lamotrigine,D(1) dopamine receptor inhibitor
lamotrigine,D(1) dopamine receptor agonist
lamotrigine,D(1) dopamine receptor antagonist
lamotrigine,Dopamine D2 receptor inhibitor
lamotrigine,Dopamine D2 receptor agonist
lamotrigine,Dopamine D2 receptor antagonist
lamotrigine,GABA(A) Receptor inhibitor
lamotrigine,GABA(A) Receptor agonist
lamotrigine,GABA(A) Receptor antagonist
lamotrigine,Histamine H1 receptor inhibitor
lamotrigine,Histamine H1 receptor agonist
lamotrigine,Histamine H1 receptor antagonist
lamotrigine,Kappa-type opioid receptor inhibitor
lamotrigine,Kappa-type opioid receptor agonist
lamotrigine,Kappa-type opioid receptor antagonist
lamotrigine,5-hydroxytryptamine receptor 2A inhibitor
lamotrigine,5-hydroxytryptamine receptor 2A agonist
lamotrigine,5-hydroxytryptamine receptor 2A antagonist
lamotrigine,5-hydroxytryptamine receptor 3A inhibitor
lamotrigine,5-hydroxytryptamine receptor 3A agonist
lamotrigine,5-hydroxytryptamine receptor 3A antagonist
methotrexate,Thymidylate synthase inhibitor
carbamazepine,Neuronal acetylcholine receptor subunit alpha-4 inhibitor
carbamazepine,Nuclear receptor subfamily 1 group I member 2 inhibitor
cisatracurium,Neuronal acetylcholine receptor subunit alpha-2 antagonist
propranolol,Beta-1 adrenergic receptor antagonist
propranolol,Beta-2 adrenergic receptor antagonist
propranolol,Beta-3 adrenergic receptor antagonist
propranolol,5-hydroxytryptamine receptor 1A antagonist
propranolol,5-hydroxytryptamine receptor 1A other/unknown
propranolol,5-hydroxytryptamine receptor 1B antagonist
atropine,Muscarinic acetylcholine receptor M1 antagonist
atropine,Muscarinic acetylcholine receptor M2 antagonist
atropine,Muscarinic acetylcholine receptor M3 antagonist
atropine,Muscarinic acetylcholine receptor M4 antagonist
atropine,Muscarinic acetylcholine receptor M5 antagonist
atropine,Neuronal acetylcholine receptor subunit alpha-4 antagonist
fenoprofen,Prostaglandin G/H synthase 2 inhibitor
fenoprofen,Prostaglandin G/H synthase 1 inhibitor
fenoprofen,Peroxisome proliferator-activated receptor alpha inhibitor
fenoprofen,Peroxisome proliferator-activated receptor gamma inhibitor
clonidine,Alpha-2A adrenergic receptor agonist
clonidine,Alpha-2B adrenergic receptor agonist
clonidine,Alpha-2C adrenergic receptor agonist
clonidine,Alpha-1A adrenergic receptor agonist
clonidine,Alpha-1B adrenergic receptor agonist
clonidine,Alpha-1D adrenergic receptor agonist
valdecoxib,Prostaglandin G/H synthase 2 inhibitor
valdecoxib,Carbonic anhydrase 2 inhibitor
valdecoxib,Carbonic anhydrase 3 inhibitor
nizatidine,Histamine H2 receptor antagonist
diclofenac,Prostaglandin G/H synthase 2 inhibitor
diclofenac,Prostaglandin G/H synthase 1 inhibitor
lisuride,Dopamine D2 receptor agonist
lisuride,Dopamine D2 receptor antagonist
lisuride,Dopamine D2 receptor other/unknown
lisuride,Dopamine D3 receptor agonist
lisuride,Dopamine D3 receptor antagonist
lisuride,Dopamine D4 receptor agonist
lisuride,Dopamine D4 receptor antagonist
lisuride,Dopamine D1 receptor agonist
lisuride,Dopamine D1 receptor antagonist
lisuride,Dopamine D5 receptor agonist
lisuride,Dopamine D5 receptor antagonist
lisuride,5-hydroxytryptamine receptor 1A agonist
lisuride,5-hydroxytryptamine receptor 1A antagonist
lisuride,5-hydroxytryptamine receptor 1A other/unknown
lisuride,5-hydroxytryptamine receptor 1D agonist
lisuride,5-hydroxytryptamine receptor 1D antagonist
lisuride,5-hydroxytryptamine receptor 2B agonist
lisuride,5-hydroxytryptamine receptor 2B antagonist
lisuride,5-hydroxytryptamine receptor 2A agonist
lisuride,5-hydroxytryptamine receptor 2A antagonist
lisuride,5-hydroxytryptamine receptor 2A other/unknown
lisuride,5-hydroxytryptamine receptor 2C agonist
lisuride,5-hydroxytryptamine receptor 2C antagonist
lisuride,5-hydroxytryptamine receptor 1B agonist
lisuride,5-hydroxytryptamine receptor 1B antagonist
lisuride,Alpha-2A adrenergic receptor agonist
lisuride,Alpha-2A adrenergic receptor antagonist
lisuride,Alpha-2B adrenergic receptor agonist
lisuride,Alpha-2B adrenergic receptor antagonist
lisuride,Alpha-2C adrenergic receptor agonist
lisuride,Alpha-2C adrenergic receptor antagonist
lisuride,5-hydroxytryptamine receptor 7 agonist
lisuride,5-hydroxytryptamine receptor 7 antagonist
doxazosin,Alpha-1A adrenergic receptor antagonist
doxazosin,Alpha-1A adrenergic receptor inhibitor
doxazosin,Alpha-1D adrenergic receptor antagonist
doxazosin,Alpha-1D adrenergic receptor inhibitor
doxazosin,Alpha-1B adrenergic receptor antagonist
doxazosin,Alpha-1B adrenergic receptor inhibitor
labetalol,Beta-1 adrenergic receptor antagonist
labetalol,Beta-2 adrenergic receptor antagonist
labetalol,Alpha-1 adrenergic receptors antagonist
sulindac,Prostaglandin G/H synthase 2 inhibitor
sulindac,Prostaglandin G/H synthase 1 inhibitor
butorphanol,Kappa-type opioid receptor agonist
butorphanol,Kappa-type opioid receptor antagonist
butorphanol,Delta-type opioid receptor agonist
butorphanol,Delta-type opioid receptor antagonist
butorphanol,Mu-type opioid receptor agonist
butorphanol,Mu-type opioid receptor antagonist
bisoprolol,Beta-1 adrenergic receptor antagonist
bisoprolol,Beta-2 adrenergic receptor antagonist
imatinib,Mast/stem cell growth factor receptor Kit inhibitor
imatinib,Tyrosine-protein kinase ABL1 inhibitor
imatinib,Platelet-derived growth factor receptor beta inhibitor
triamcinolone,Glucocorticoid receptor agonist
nicardipine,Voltage-dependent L-type calcium channel subunit alpha-1C inhibitor
nicardipine,Voltage-dependent L-type calcium channel subunit beta-2 inhibitor
nicardipine,Voltage-dependent calcium channel subunit alpha-2/delta-1 inhibitor
nicardipine,Voltage-dependent L-type calcium channel subunit alpha-1D inhibitor
nicardipine,Alpha-1A adrenergic receptor inhibitor
nicardipine,Alpha-1A adrenergic receptor antagonist
nicardipine,Alpha-1B adrenergic receptor inhibitor
nicardipine,Alpha-1B adrenergic receptor antagonist
nicardipine,Alpha-1D adrenergic receptor inhibitor
nicardipine,Alpha-1D adrenergic receptor antagonist
nicardipine,Muscarinic acetylcholine receptor M1 inhibitor
nicardipine,Muscarinic acetylcholine receptor M1 antagonist
nicardipine,Muscarinic acetylcholine receptor M2 inhibitor
nicardipine,Muscarinic acetylcholine receptor M2 antagonist
nicardipine,Muscarinic acetylcholine receptor M3 inhibitor
nicardipine,Muscarinic acetylcholine receptor M3 antagonist
nicardipine,Muscarinic acetylcholine receptor M4 inhibitor
nicardipine,Muscarinic acetylcholine receptor M4 antagonist
nicardipine,Muscarinic acetylcholine receptor M5 inhibitor
nicardipine,Muscarinic acetylcholine receptor M5 antagonist
nicardipine,Calmodulin inhibitor
nicardipine,Calmodulin antagonist
fluphenazine,Dopamine D2 receptor antagonist
fluphenazine,Dopamine D2 receptor inhibitor
fluphenazine,Dopamine D1 receptor antagonist
fluphenazine,Dopamine D1 receptor inhibitor
fluphenazine,Calmodulin antagonist
fluphenazine,Calmodulin inhibitor
fluphenazine,Androgen receptor antagonist
fluphenazine,Androgen receptor inhibitor
fluphenazine,5-hydroxytryptamine receptor 2A antagonist
fluphenazine,5-hydroxytryptamine receptor 2A inhibitor
fluphenazine,5-hydroxytryptamine receptor 2C antagonist
fluphenazine,5-hydroxytryptamine receptor 2C inhibitor
testosterone,Androgen receptor agonist
testosterone,Androgen receptor inhibitor
testosterone,Estrogen receptor alpha agonist
testosterone,Estrogen receptor alpha inhibitor
efavirenz,Reverse transcriptase/RNaseH inhibitor
clofarabine,DNA inhibitor
dexmedetomidine,Alpha-2A adrenergic receptor agonist
prednisone,Glucocorticoid receptor agonist
pemetrexed,Thymidylate synthase inhibitor
dyphylline,Adenosine receptor A1 inhibitor
dyphylline,Adenosine receptor A1 antagonist
pentazocine,Mu-type opioid receptor antagonist
pentazocine,Mu-type opioid receptor agonist
pentazocine,Kappa-type opioid receptor antagonist
pentazocine,Kappa-type opioid receptor agonist
estrone,Estrogen receptor alpha agonist
estrone,Estrogen receptor beta agonist
estrone,Androgen receptor agonist
trazodone,5-hydroxytryptamine receptor 2A antagonist
trazodone,5-hydroxytryptamine receptor 2A agonist
trazodone,5-hydroxytryptamine receptor 2A inhibitor
trazodone,5-hydroxytryptamine receptor 2C antagonist
trazodone,5-hydroxytryptamine receptor 2C agonist
trazodone,5-hydroxytryptamine receptor 2C inhibitor
trazodone,Sodium-dependent serotonin transporter antagonist
trazodone,Sodium-dependent serotonin transporter agonist
trazodone,Sodium-dependent serotonin transporter inhibitor
trazodone,5-hydroxytryptamine receptor 1A antagonist
trazodone,5-hydroxytryptamine receptor 1A agonist
trazodone,5-hydroxytryptamine receptor 1A inhibitor
trazodone,5-hydroxytryptamine receptor 1A partial agonist
trazodone,Histamine H1 receptor antagonist
trazodone,Histamine H1 receptor agonist
trazodone,Histamine H1 receptor inhibitor
trazodone,Alpha-1A adrenergic receptor antagonist
trazodone,Alpha-1A adrenergic receptor agonist
trazodone,Alpha-1A adrenergic receptor inhibitor
trazodone,Alpha-2A adrenergic receptor antagonist
trazodone,Alpha-2A adrenergic receptor agonist
trazodone,Alpha-2A adrenergic receptor inhibitor
verapamil,Voltage-dependent L-type calcium channel subunit alpha-1C inhibitor
verapamil,Potassium voltage-gated channel subfamily H member 2 inhibitor
verapamil,Potassium voltage-gated channel subfamily H member 2 antagonist
verapamil,Sodium-dependent serotonin transporter inhibitor
verapamil,Sodium-dependent serotonin transporter antagonist
verapamil,Alpha-1A adrenergic receptor inhibitor
verapamil,Alpha-1A adrenergic receptor antagonist
verapamil,Alpha-1B adrenergic receptor inhibitor
verapamil,Alpha-1B adrenergic receptor antagonist
verapamil,Alpha-1D adrenergic receptor inhibitor
verapamil,Alpha-1D adrenergic receptor antagonist
nilutamide,Androgen receptor antagonist
epinephrine,Alpha-1A adrenergic receptor agonist
epinephrine,Alpha-1A adrenergic receptor antagonist
epinephrine,Alpha-1B adrenergic receptor agonist
epinephrine,Alpha-1B adrenergic receptor antagonist
epinephrine,Beta-1 adrenergic receptor agonist
epinephrine,Beta-1 adrenergic receptor antagonist
epinephrine,Beta-2 adrenergic receptor agonist
epinephrine,Beta-2 adrenergic receptor antagonist
epinephrine,Alpha-2A adrenergic receptor agonist
epinephrine,Alpha-2A adrenergic receptor antagonist
epinephrine,Alpha-2B adrenergic receptor agonist
epinephrine,Alpha-2B adrenergic receptor antagonist
epinephrine,Alpha-1D adrenergic receptor agonist
epinephrine,Alpha-1D adrenergic receptor antagonist
sumatriptan,5-hydroxytryptamine receptor 1D agonist
sumatriptan,5-hydroxytryptamine receptor 1B agonist
sumatriptan,5-hydroxytryptamine receptor 1F agonist
sumatriptan,5-hydroxytryptamine receptor 1A agonist
galantamine,Acetylcholinesterase inhibitor
galantamine,Cholinesterase inhibitor
tamoxifen,Estrogen receptor alpha antagonist
tamoxifen,Estrogen receptor alpha agonist
tamoxifen,Estrogen receptor alpha inhibitor
tamoxifen,Estrogen receptor beta agonist
tamoxifen,Androgen receptor antagonist
tamoxifen,Androgen receptor agonist
tamoxifen,Androgen receptor inhibitor
tamoxifen,Potassium voltage-gated channel subfamily H member 2 antagonist
tamoxifen,Potassium voltage-gated channel subfamily H member 2 inhibitor
tamoxifen,Nuclear receptor subfamily 1 group I member 2 agonist
tamoxifen,Nuclear receptor subfamily 1 group I member 2 inhibitor
losartan,Type-1 angiotensin II receptor antagonist
thioridazine,Dopamine D2 receptor antagonist
thioridazine,Dopamine D2 receptor inhibitor
thioridazine,Dopamine D1 receptor antagonist
thioridazine,Dopamine D1 receptor inhibitor
thioridazine,Alpha-1A adrenergic receptor antagonist
thioridazine,Alpha-1A adrenergic receptor inhibitor
thioridazine,Alpha-1B adrenergic receptor antagonist
thioridazine,Alpha-1B adrenergic receptor inhibitor
thioridazine,5-hydroxytryptamine receptor 2A antagonist
thioridazine,5-hydroxytryptamine receptor 2A inhibitor
thioridazine,Potassium voltage-gated channel subfamily H member 2 antagonist
thioridazine,Potassium voltage-gated channel subfamily H member 2 inhibitor
midazolam,GABA(A) Receptor ligand
midazolam,GABA(A) Receptor Benzodiazepine Binding Site ligand
trovafloxacin,DNA gyrase subunit A inhibitor
trovafloxacin,DNA topoisomerase 4 subunit A inhibitor
trovafloxacin,DNA topoisomerase 2-alpha inhibitor
fludrocortisone,Glucocorticoid receptor agonist
phentolamine,Alpha-2A adrenergic receptor antagonist
phentolamine,Alpha-1A adrenergic receptor antagonist
phentolamine,Alpha-1B adrenergic receptor antagonist
phentolamine,Alpha-1D adrenergic receptor antagonist
ergotamine,5-hydroxytryptamine receptor 1D agonist
ergotamine,5-hydroxytryptamine receptor 1B agonist
ergotamine,5-hydroxytryptamine receptor 2A agonist
ergotamine,Dopamine D2 receptor agonist
ergotamine,Alpha-1A adrenergic receptor agonist
ergotamine,Alpha-1B adrenergic receptor agonist
ergotamine,Alpha-1D adrenergic receptor agonist
ergotamine,Alpha-2A adrenergic receptor agonist
ergotamine,D(1) dopamine receptor agonist
ergotamine,5-hydroxytryptamine receptor 1A agonist
ergotamine,5-hydroxytryptamine receptor 1A partial agonist
ergotamine,5-hydroxytryptamine receptor 1F agonist
ergotamine,5-hydroxytryptamine receptor 2C agonist
ergotamine,5-hydroxytryptamine receptor 2B agonist
ergotamine,Alpha-2C adrenergic receptor agonist
tizanidine,Alpha-2 adrenergic receptors agonist
tizanidine,Alpha-1 adrenergic receptors agonist
amprenavir,Human immunodeficiency virus type 1 protease inhibitor
naltrexone,Delta-type opioid receptor antagonist
naltrexone,Mu-type opioid receptor antagonist
naltrexone,Kappa-type opioid receptor antagonist
delavirdine,Reverse transcriptase/RNaseH inhibitor
tamsulosin,Alpha-1A adrenergic receptor antagonist
tamsulosin,Alpha-1D adrenergic receptor antagonist
tamsulosin,Alpha-1B adrenergic receptor antagonist
sufentanil,Mu-type opioid receptor agonist
sufentanil,Delta-type opioid receptor agonist
sufentanil,Kappa-type opioid receptor agonist
lamivudine,Reverse transcriptase/RNaseH inhibitor
lamivudine,DNA inhibitor
flurbiprofen,Prostaglandin G/H synthase 1 inhibitor
flurbiprofen,Prostaglandin G/H synthase 2 inhibitor
apomorphine,Dopamine D4 receptor agonist
apomorphine,Dopamine D2 receptor agonist
apomorphine,Dopamine D3 receptor agonist
apomorphine,Dopamine D5 receptor agonist
apomorphine,Dopamine D1 receptor agonist
apomorphine,Alpha-2C adrenergic receptor agonist
apomorphine,Alpha-2B adrenergic receptor agonist
apomorphine,5-hydroxytryptamine receptor 1A agonist
apomorphine,5-hydroxytryptamine receptor 2A agonist
apomorphine,5-hydroxytryptamine receptor 2B agonist
apomorphine,5-hydroxytryptamine receptor 2C agonist
apomorphine,Alpha-2A adrenergic receptor agonist
apomorphine,5-hydroxytryptamine receptor 1D agonist
apomorphine,5-hydroxytryptamine receptor 1B agonist
paroxetine,Sodium-dependent serotonin transporter inhibitor
paroxetine,Sodium-dependent serotonin transporter agonist
paroxetine,Sodium-dependent serotonin transporter binder
paroxetine,Sodium-dependent noradrenaline transporter inhibitor
paroxetine,Sodium-dependent noradrenaline transporter agonist
paroxetine,Sodium-dependent noradrenaline transporter binder
paroxetine,5-hydroxytryptamine receptor 2A inhibitor
paroxetine,5-hydroxytryptamine receptor 2A agonist
paroxetine,5-hydroxytryptamine receptor 2A binder
paroxetine,5-hydroxytryptamine receptor 2A other/unknown
paroxetine,Alpha-1 adrenergic receptors inhibitor
paroxetine,Alpha-1 adrenergic receptors agonist
paroxetine,Alpha-1 adrenergic receptors binder
paroxetine,Alpha-2 adrenergic receptors inhibitor
paroxetine,Alpha-2 adrenergic receptors agonist
paroxetine,Alpha-2 adrenergic receptors binder
paroxetine,Beta adrenergic receptor inhibitor
paroxetine,Dopamine D2 receptor inhibitor
paroxetine,Dopamine D2 receptor agonist
paroxetine,Dopamine D2 receptor binder
paroxetine,Dopamine D2 receptor other/unknown
paroxetine,Histamine H1 receptor inhibitor
paroxetine,Histamine H1 receptor agonist
paroxetine,Histamine H1 receptor binder
paroxetine,Muscarinic acetylcholine receptor inhibitor
paroxetine,Muscarinic acetylcholine receptor binder
paroxetine,5-hydroxytryptamine receptor 2B inhibitor
paroxetine,5-hydroxytryptamine receptor 2B agonist
paroxetine,5-hydroxytryptamine receptor 2B binder
paroxetine,D(1) dopamine receptor inhibitor
paroxetine,D(1) dopamine receptor agonist
paroxetine,D(1) dopamine receptor binder
norethisterone,Androgen receptor agonist
norethisterone,Glucocorticoid receptor agonist
procaine,Sodium channel protein type 10 subunit alpha inhibitor
procaine,5-hydroxytryptamine receptor 3A inhibitor
procaine,5-hydroxytryptamine receptor 3A antagonist
procaine,Sodium-dependent dopamine transporter inhibitor
procaine,Sodium-dependent dopamine transporter antagonist
procaine,Neuronal acetylcholine receptor subunit alpha-2 antagonist
lisinopril,Angiotensin-converting enzyme inhibitor
trimipramine,Sodium-dependent serotonin transporter inhibitor
trimipramine,Sodium-dependent serotonin transporter agonist
trimipramine,Sodium-dependent serotonin transporter antagonist
trimipramine,Sodium-dependent serotonin transporter binder
trimipramine,Sodium-dependent noradrenaline transporter inhibitor
trimipramine,Sodium-dependent noradrenaline transporter agonist
trimipramine,Sodium-dependent noradrenaline transporter antagonist
trimipramine,Sodium-dependent noradrenaline transporter binder
trimipramine,Sodium-dependent dopamine transporter inhibitor
trimipramine,Sodium-dependent dopamine transporter agonist
trimipramine,Sodium-dependent dopamine transporter antagonist
trimipramine,Sodium-dependent dopamine transporter binder
trimipramine,5-hydroxytryptamine receptor 2A inhibitor
trimipramine,5-hydroxytryptamine receptor 2A agonist
trimipramine,5-hydroxytryptamine receptor 2A antagonist
trimipramine,5-hydroxytryptamine receptor 2A other/unknown
trimipramine,5-hydroxytryptamine receptor 2A binder
trimipramine,5-hydroxytryptamine receptor 1A inhibitor
trimipramine,5-hydroxytryptamine receptor 1A agonist
trimipramine,5-hydroxytryptamine receptor 1A antagonist
trimipramine,5-hydroxytryptamine receptor 1A other/unknown
trimipramine,5-hydroxytryptamine receptor 1A binder
trimipramine,Alpha-1A adrenergic receptor inhibitor
trimipramine,Alpha-1A adrenergic receptor agonist
trimipramine,Alpha-1A adrenergic receptor antagonist
trimipramine,Alpha-1A adrenergic receptor binder
trimipramine,Alpha-1B adrenergic receptor inhibitor
trimipramine,Alpha-1B adrenergic receptor agonist
trimipramine,Alpha-1B adrenergic receptor antagonist
trimipramine,Alpha-1B adrenergic receptor binder
trimipramine,Dopamine D2 receptor inhibitor
trimipramine,Dopamine D2 receptor agonist
trimipramine,Dopamine D2 receptor antagonist
trimipramine,Dopamine D2 receptor other/unknown
trimipramine,Dopamine D2 receptor binder
trimipramine,Alpha-2B adrenergic receptor inhibitor
trimipramine,Alpha-2B adrenergic receptor agonist
trimipramine,Alpha-2B adrenergic receptor antagonist
trimipramine,Alpha-2B adrenergic receptor binder
trimipramine,Histamine H1 receptor inhibitor
trimipramine,Histamine H1 receptor agonist
trimipramine,Histamine H1 receptor antagonist
trimipramine,Histamine H1 receptor binder
trimipramine,5-hydroxytryptamine receptor 2C inhibitor
trimipramine,5-hydroxytryptamine receptor 2C agonist
trimipramine,5-hydroxytryptamine receptor 2C antagonist
trimipramine,5-hydroxytryptamine receptor 2C binder
trimipramine,5-hydroxytryptamine receptor 3A inhibitor
trimipramine,5-hydroxytryptamine receptor 3A agonist
trimipramine,5-hydroxytryptamine receptor 3A antagonist
trimipramine,5-hydroxytryptamine receptor 3A binder
trimipramine,5-hydroxytryptamine receptor 1D agonist
trimipramine,5-hydroxytryptamine receptor 1D antagonist
trimipramine,Alpha-2A adrenergic receptor inhibitor
trimipramine,Alpha-2A adrenergic receptor agonist
trimipramine,Alpha-2A adrenergic receptor antagonist
trimipramine,Alpha-2A adrenergic receptor binder
trimipramine,D(1) dopamine receptor inhibitor
trimipramine,D(1) dopamine receptor agonist
trimipramine,D(1) dopamine receptor antagonist
trimipramine,D(1) dopamine receptor binder
trimipramine,Beta adrenergic receptor inhibitor
trimipramine,Muscarinic acetylcholine receptor inhibitor
trimipramine,Muscarinic acetylcholine receptor antagonist
trimipramine,Muscarinic acetylcholine receptor binder
rocuronium,Neuronal acetylcholine receptor subunit alpha-2 antagonist
rocuronium,Muscarinic acetylcholine receptor M2 antagonist
rocuronium,5-hydroxytryptamine receptor 3A antagonist
risperidone,5-hydroxytryptamine receptor 2A antagonist
risperidone,Dopamine D2 receptor antagonist
risperidone,Alpha-1B adrenergic receptor antagonist
risperidone,Alpha-2B adrenergic receptor antagonist
risperidone,Alpha-1A adrenergic receptor antagonist
risperidone,Alpha-2C adrenergic receptor antagonist
risperidone,Histamine H1 receptor antagonist
risperidone,5-hydroxytryptamine receptor 2C antagonist
risperidone,5-hydroxytryptamine receptor 1D antagonist
risperidone,5-hydroxytryptamine receptor 1A antagonist
risperidone,5-hydroxytryptamine receptor 7 antagonist
risperidone,Dopamine D1 receptor antagonist
riluzole,Sodium channel protein type 5 subunit alpha inhibitor
modafinil,Sodium-dependent dopamine transporter inhibitor
modafinil,Alpha-1B adrenergic receptor inhibitor
scopolamine,Muscarinic acetylcholine receptor M1 antagonist
scopolamine,Muscarinic acetylcholine receptor M1 inhibitor
scopolamine,Muscarinic acetylcholine receptor M2 antagonist
scopolamine,Muscarinic acetylcholine receptor M2 inhibitor
scopolamine,Muscarinic acetylcholine receptor M3 antagonist
scopolamine,Muscarinic acetylcholine receptor M3 inhibitor
scopolamine,Muscarinic acetylcholine receptor M4 antagonist
scopolamine,Muscarinic acetylcholine receptor M4 inhibitor
scopolamine,Muscarinic acetylcholine receptor M5 antagonist
scopolamine,Muscarinic acetylcholine receptor M5 inhibitor
scopolamine,Neuronal acetylcholine receptor subunit alpha-4 antagonist
scopolamine,Neuronal acetylcholine receptor subunit alpha-4 inhibitor
carbinoxamine,Histamine H1 receptor antagonist
etodolac,Prostaglandin G/H synthase 2 inhibitor
etodolac,Prostaglandin G/H synthase 1 inhibitor
prilocaine,Sodium channel protein type 5 subunit alpha inhibitor
tranylcypromine,Amine oxidase [flavin-containing] B inhibitor
isoflurane,Gamma-aminobutyric acid receptor subunit alpha-1 agonist
isoflurane,Gamma-aminobutyric acid receptor subunit alpha-1 antagonist
isoflurane,Calmodulin inhibitor
isoflurane,Calmodulin antagonist
isoflurane,GABA(A) Receptor agonist
isoflurane,GABA(A) Receptor inhibitor
isoflurane,GABA(A) Receptor antagonist
isoflurane,Neuronal acetylcholine receptor subunit alpha-4 agonist
isoflurane,Neuronal acetylcholine receptor subunit alpha-4 inhibitor
isoflurane,Neuronal acetylcholine receptor subunit alpha-4 antagonist
dolasetron,5-hydroxytryptamine receptor 3A antagonist
etoposide,DNA topoisomerase 2-alpha inhibitor
phenelzine,Amine oxidase [flavin-containing] B inhibitor
propantheline,Muscarinic acetylcholine receptor M1 antagonist
estradiol,Estrogen receptor alpha agonist
estradiol,Estrogen receptor alpha inhibitor
estradiol,Estrogen receptor beta agonist
estradiol,Nuclear receptor subfamily 1 group I member 2 agonist
estradiol,Nuclear receptor subfamily 1 group I member 2 inhibitor
estradiol,Neuronal acetylcholine receptor subunit alpha-4 agonist
estradiol,Neuronal acetylcholine receptor subunit alpha-4 inhibitor
acyclovir,DNA polymerase catalytic subunit inhibitor
acyclovir,DNA polymerase catalytic subunit inhibitor
naproxen,Prostaglandin G/H synthase 1 inhibitor
naproxen,Prostaglandin G/H synthase 2 inhibitor
perindopril,Angiotensin-converting enzyme inhibitor
sulfasalazine,Prostaglandin G/H synthase 2 inhibitor
sulfasalazine,Prostaglandin G/H synthase 1 inhibitor
sulfasalazine,Peroxisome proliferator-activated receptor gamma inhibitor
sulfasalazine,Peroxisome proliferator-activated receptor gamma agonist
fenoldopam,Dopamine D5 receptor agonist
fenoldopam,Dopamine D5 receptor antagonist
fenoldopam,Dopamine D1 receptor agonist
fenoldopam,Dopamine D1 receptor antagonist
fenoldopam,Dopamine D1 receptor inhibitor
fenoldopam,Alpha-2B adrenergic receptor agonist
fenoldopam,Alpha-2B adrenergic receptor antagonist
fenoldopam,Alpha-2B adrenergic receptor inhibitor
fenoldopam,Alpha-2C adrenergic receptor agonist
fenoldopam,Alpha-2C adrenergic receptor antagonist
fenoldopam,Alpha-2C adrenergic receptor inhibitor
fenoldopam,Alpha-2A adrenergic receptor agonist
fenoldopam,Alpha-2A adrenergic receptor antagonist
fenoldopam,Alpha-2A adrenergic receptor inhibitor
fenoldopam,Alpha-1B adrenergic receptor agonist
fenoldopam,Alpha-1B adrenergic receptor antagonist
fenoldopam,Alpha-1B adrenergic receptor inhibitor
fenoldopam,Alpha-1D adrenergic receptor agonist
fenoldopam,Alpha-1D adrenergic receptor antagonist
fenoldopam,Alpha-1D adrenergic receptor inhibitor
fenoldopam,Alpha-1A adrenergic receptor agonist
fenoldopam,Alpha-1A adrenergic receptor antagonist
fenoldopam,Alpha-1A adrenergic receptor inhibitor
alfentanil,Mu-type opioid receptor agonist
dicyclomine,Muscarinic acetylcholine receptor M1 antagonist
dicyclomine,Muscarinic acetylcholine receptor M3 antagonist
dicyclomine,Muscarinic acetylcholine receptor M2 antagonist
pentoxifylline,Adenosine receptor A1 inhibitor
tropicamide,Muscarinic acetylcholine receptor M4 antagonist
tropicamide,Muscarinic acetylcholine receptor M3 antagonist
tropicamide,Muscarinic acetylcholine receptor M1 antagonist
tropicamide,Muscarinic acetylcholine receptor M2 antagonist
fentanyl,Mu-type opioid receptor agonist
fentanyl,Delta-type opioid receptor agonist
fentanyl,Kappa-type opioid receptor agonist
meloxicam,Prostaglandin G/H synthase 2 inhibitor
meloxicam,Prostaglandin G/H synthase 1 inhibitor
propofol,GABA(A) Receptor inhibitor
tadalafil,"cGMP-specific 3',5'-cyclic phosphodiesterase inhibitor"
diazepam,GABA(A) Receptor ligand
diazepam,GABA(A) Receptor Benzodiazepine Binding Site ligand
trifluoperazine,Dopamine D2 receptor antagonist
trifluoperazine,Dopamine D2 receptor inhibitor
trifluoperazine,Alpha-1A adrenergic receptor antagonist
trifluoperazine,Alpha-1A adrenergic receptor inhibitor
trifluoperazine,Calmodulin antagonist
trifluoperazine,Calmodulin inhibitor
dobutamine,Beta-1 adrenergic receptor agonist
dobutamine,Beta-2 adrenergic receptor agonist
dobutamine,Alpha-1 adrenergic receptors agonist
dobutamine,Estrogen receptor alpha agonist
donepezil,Acetylcholinesterase inhibitor
donepezil,5-hydroxytryptamine receptor 2A inhibitor
donepezil,Cholinesterase inhibitor
nalbuphine,Kappa-type opioid receptor agonist
nalbuphine,Kappa-type opioid receptor antagonist
nalbuphine,Mu-type opioid receptor agonist
nalbuphine,Mu-type opioid receptor antagonist
nalbuphine,Delta-type opioid receptor agonist
nalbuphine,Delta-type opioid receptor antagonist
perphenazine,Dopamine D2 receptor antagonist
perphenazine,Dopamine D2 receptor inhibitor
perphenazine,Dopamine D1 receptor antagonist
perphenazine,Dopamine D1 receptor inhibitor
perphenazine,Calmodulin antagonist
perphenazine,Calmodulin inhibitor
prednisolone,Glucocorticoid receptor agonist
vardenafil,"cGMP-specific 3',5'-cyclic phosphodiesterase inhibitor"
ranitidine,Histamine H2 receptor antagonist
ranitidine,Acetylcholinesterase inhibitor
benzphetamine,Synaptic vesicular amine transporter inhibitor
benzphetamine,Alpha-2A adrenergic receptor agonist
benzphetamine,Alpha-2A adrenergic receptor inhibitor
benzphetamine,Alpha-1A adrenergic receptor agonist
benzphetamine,Alpha-1A adrenergic receptor inhibitor
benzphetamine,Sodium-dependent dopamine transporter agonist
benzphetamine,Sodium-dependent dopamine transporter inhibitor
dorzolamide,Carbonic anhydrase 2 inhibitor
dorzolamide,Carbonic anhydrase 1 inhibitor
dorzolamide,Carbonic anhydrase 3 inhibitor
terbutaline,Beta-2 adrenergic receptor agonist
terbutaline,Beta-2 adrenergic receptor antagonist
terbutaline,Beta-3 adrenergic receptor agonist
terbutaline,Beta-3 adrenergic receptor antagonist
terbutaline,Beta-1 adrenergic receptor agonist
terbutaline,Beta-1 adrenergic receptor antagonist
eprosartan,Type-1 angiotensin II receptor antagonist
quinapril,Angiotensin-converting enzyme inhibitor
granisetron,5-hydroxytryptamine receptor 3A antagonist
triazolam,GABA(A) Receptor ligand
triazolam,GABA(A) Receptor Benzodiazepine Binding Site ligand
remifentanil,Mu-type opioid receptor agonist
remifentanil,Delta-type opioid receptor agonist
remifentanil,Kappa-type opioid receptor agonist
ondansetron,5-hydroxytryptamine receptor 3A antagonist
ondansetron,5-hydroxytryptamine receptor 3A agonist
ondansetron,Mu-type opioid receptor antagonist
ondansetron,Mu-type opioid receptor agonist
ondansetron,5-hydroxytryptamine receptor 1A antagonist
ondansetron,5-hydroxytryptamine receptor 1A agonist
ondansetron,5-hydroxytryptamine receptor 1A other/unknown
ondansetron,5-hydroxytryptamine receptor 1B antagonist
ondansetron,5-hydroxytryptamine receptor 1B agonist
quinidine,Sodium channel protein type 5 subunit alpha inhibitor
quinidine,Potassium voltage-gated channel subfamily H member 2 inhibitor
quinidine,Potassium voltage-gated channel subfamily H member 2 antagonist
quinidine,Alpha-1A adrenergic receptor inhibitor
quinidine,Alpha-1A adrenergic receptor antagonist
quinidine,Alpha-1B adrenergic receptor inhibitor
quinidine,Alpha-1B adrenergic receptor antagonist
quinidine,Alpha-1D adrenergic receptor inhibitor
quinidine,Alpha-1D adrenergic receptor antagonist
zonisamide,Sodium channel protein type 5 subunit alpha inhibitor
zonisamide,Carbonic anhydrase 1 inhibitor
zonisamide,Carbonic anhydrase 2 inhibitor
zonisamide,Carbonic anhydrase 3 inhibitor
zonisamide,Amine oxidase [flavin-containing] B inhibitor
repaglinide,Peroxisome proliferator-activated receptor gamma inhibitor
repaglinide,Peroxisome proliferator-activated receptor gamma agonist
amantadine,Neuronal acetylcholine receptor subunit alpha-7 antagonist
amantadine,Dopamine D2 receptor inhibitor
amantadine,Dopamine D2 receptor antagonist
amantadine,Dopamine D2 receptor agonist
amantadine,Neuronal acetylcholine receptor subunit alpha-4 inhibitor
amantadine,Neuronal acetylcholine receptor subunit alpha-4 antagonist
amantadine,Neuronal acetylcholine receptor subunit alpha-4 agonist
almotriptan,5-hydroxytryptamine receptor 1B agonist
almotriptan,5-hydroxytryptamine receptor 1D agonist
buprenorphine,Mu-type opioid receptor antagonist
buprenorphine,Kappa-type opioid receptor partial agonist
buprenorphine,Kappa-type opioid receptor antagonist
buprenorphine,Delta-type opioid receptor antagonist
levosimendan,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A inhibitor"
cyclobenzaprine,5-hydroxytryptamine receptor 2A antagonist
cyclobenzaprine,5-hydroxytryptamine receptor 2A inhibitor
cyclobenzaprine,5-hydroxytryptamine receptor 2B antagonist
cyclobenzaprine,5-hydroxytryptamine receptor 2B inhibitor
cyclobenzaprine,5-hydroxytryptamine receptor 2C antagonist
cyclobenzaprine,5-hydroxytryptamine receptor 2C inhibitor
cyclobenzaprine,5-hydroxytryptamine receptor 6 antagonist
cyclobenzaprine,5-hydroxytryptamine receptor 6 inhibitor
cyclobenzaprine,Sodium-dependent serotonin transporter antagonist
cyclobenzaprine,Sodium-dependent serotonin transporter inhibitor
cyclobenzaprine,Sodium-dependent noradrenaline transporter antagonist
cyclobenzaprine,Sodium-dependent noradrenaline transporter inhibitor
cyclobenzaprine,5-hydroxytryptamine receptor 7 antagonist
cyclobenzaprine,5-hydroxytryptamine receptor 7 inhibitor
phenoxybenzamine,Alpha-1A adrenergic receptor antagonist
phenoxybenzamine,Alpha-1A adrenergic receptor inhibitor
phenoxybenzamine,Alpha-2A adrenergic receptor antagonist
phenoxybenzamine,Alpha-2A adrenergic receptor inhibitor
phenoxybenzamine,Alpha-2C adrenergic receptor antagonist
phenoxybenzamine,Alpha-2C adrenergic receptor inhibitor
phenoxybenzamine,Alpha-2B adrenergic receptor antagonist
phenoxybenzamine,Alpha-2B adrenergic receptor inhibitor
phenoxybenzamine,Calmodulin antagonist
phenoxybenzamine,Calmodulin inhibitor
phenoxybenzamine,Beta-2 adrenergic receptor antagonist
phenoxybenzamine,Beta-2 adrenergic receptor inhibitor
phenoxybenzamine,Alpha-1B adrenergic receptor antagonist
phenoxybenzamine,Alpha-1B adrenergic receptor inhibitor
phenoxybenzamine,Alpha-1D adrenergic receptor antagonist
phenoxybenzamine,Alpha-1D adrenergic receptor inhibitor
famotidine,Histamine H2 receptor antagonist
maprotiline,Sodium-dependent noradrenaline transporter inhibitor
maprotiline,Sodium-dependent noradrenaline transporter antagonist
maprotiline,Sodium-dependent noradrenaline transporter binder
maprotiline,Histamine H1 receptor inhibitor
maprotiline,Histamine H1 receptor antagonist
maprotiline,Histamine H1 receptor binder
maprotiline,Muscarinic acetylcholine receptor M1 inhibitor
maprotiline,Muscarinic acetylcholine receptor M1 antagonist
maprotiline,Muscarinic acetylcholine receptor M1 binder
maprotiline,Muscarinic acetylcholine receptor M2 inhibitor
maprotiline,Muscarinic acetylcholine receptor M2 antagonist
maprotiline,Muscarinic acetylcholine receptor M3 inhibitor
maprotiline,Muscarinic acetylcholine receptor M3 antagonist
maprotiline,Muscarinic acetylcholine receptor M3 binder
maprotiline,Muscarinic acetylcholine receptor M4 inhibitor
maprotiline,Muscarinic acetylcholine receptor M4 antagonist
maprotiline,Muscarinic acetylcholine receptor M5 inhibitor
maprotiline,Muscarinic acetylcholine receptor M5 antagonist
maprotiline,Alpha-1 adrenergic receptors inhibitor
maprotiline,Alpha-1 adrenergic receptors antagonist
maprotiline,Alpha-1 adrenergic receptors binder
maprotiline,5-hydroxytryptamine receptor 2A inhibitor
maprotiline,5-hydroxytryptamine receptor 2A antagonist
maprotiline,5-hydroxytryptamine receptor 2A binder
maprotiline,5-hydroxytryptamine receptor 2C inhibitor
maprotiline,5-hydroxytryptamine receptor 2C antagonist
maprotiline,5-hydroxytryptamine receptor 2C binder
maprotiline,5-hydroxytryptamine receptor 7 inhibitor
maprotiline,5-hydroxytryptamine receptor 7 antagonist
maprotiline,5-hydroxytryptamine receptor 7 binder
maprotiline,Dopamine D2 receptor inhibitor
maprotiline,Dopamine D2 receptor antagonist
maprotiline,Dopamine D2 receptor binder
maprotiline,Alpha-2 adrenergic receptors inhibitor
maprotiline,Alpha-2 adrenergic receptors antagonist
maprotiline,Alpha-2 adrenergic receptors binder
diethylpropion,Sodium-dependent noradrenaline transporter inhibitor
diethylpropion,Sodium-dependent dopamine transporter inhibitor
salmeterol,Beta-2 adrenergic receptor agonist
salmeterol,Beta-1 adrenergic receptor agonist
salmeterol,Beta-3 adrenergic receptor agonist
zalcitabine,Reverse transcriptase/RNaseH inhibitor
fexofenadine,Histamine H1 receptor antagonist
naratriptan,5-hydroxytryptamine receptor 1D agonist
naratriptan,5-hydroxytryptamine receptor 1B agonist
naratriptan,5-hydroxytryptamine receptor 1F agonist
naratriptan,5-hydroxytryptamine receptor 1A agonist
rizatriptan,5-hydroxytryptamine receptor 1D agonist
rizatriptan,5-hydroxytryptamine receptor 1B agonist
rizatriptan,5-hydroxytryptamine receptor 1F agonist
hydrocodone,Mu-type opioid receptor agonist
hydrocodone,Delta-type opioid receptor agonist
methylprednisolone,Glucocorticoid receptor agonist
pindolol,Beta-1 adrenergic receptor partial agonist
pindolol,Beta-1 adrenergic receptor antagonist
pindolol,Beta-1 adrenergic receptor inhibitor
pindolol,Beta-1 adrenergic receptor agonist
pindolol,Beta-2 adrenergic receptor partial agonist
pindolol,Beta-2 adrenergic receptor antagonist
pindolol,Beta-2 adrenergic receptor inhibitor
pindolol,Beta-2 adrenergic receptor agonist
pindolol,5-hydroxytryptamine receptor 1A partial agonist
pindolol,5-hydroxytryptamine receptor 1A antagonist
pindolol,5-hydroxytryptamine receptor 1A inhibitor
pindolol,5-hydroxytryptamine receptor 1A other/unknown
pindolol,5-hydroxytryptamine receptor 1A agonist
pindolol,5-hydroxytryptamine receptor 1B antagonist
pindolol,5-hydroxytryptamine receptor 1B agonist
pindolol,Beta-3 adrenergic receptor antagonist
pindolol,Beta-3 adrenergic receptor agonist
pindolol,Beta adrenergic receptor inhibitor
mepivacaine,Sodium channel protein type 10 subunit alpha inhibitor
zaleplon,Gamma-aminobutyric acid receptor subunit alpha-1 potentiator
apraclonidine,Alpha-2A adrenergic receptor agonist
apraclonidine,Alpha-1A adrenergic receptor agonist
apraclonidine,Alpha-2B adrenergic receptor agonist
telmisartan,Type-1 angiotensin II receptor antagonist
desloratadine,Histamine H1 receptor antagonist
methyldopa,Alpha-2A adrenergic receptor agonist
methyldopa,Alpha-2A adrenergic receptor inhibitor
azelastine,Histamine H1 receptor antagonist
azelastine,Histamine H1 receptor inhibitor
azelastine,Histamine H2 receptor antagonist
dipyridamole,"cGMP-specific 3',5'-cyclic phosphodiesterase inhibitor"
lomefloxacin,DNA topoisomerase 4 subunit A inhibitor
lomefloxacin,DNA gyrase subunit A inhibitor
lomefloxacin,DNA topoisomerase 2-alpha inhibitor
cyclopentolate,Muscarinic acetylcholine receptor M1 antagonist
physostigmine,Acetylcholinesterase inhibitor
physostigmine,Neuronal acetylcholine receptor subunit alpha-4 inhibitor
formoterol,Beta-2 adrenergic receptor agonist
formoterol,Beta-1 adrenergic receptor agonist
formoterol,Beta-3 adrenergic receptor agonist
dimenhydrinate,Histamine H1 receptor antagonist
cytarabine,DNA inhibitor
dopamine,Dopamine D2 receptor agonist
dopamine,Dopamine D2 receptor binder
dopamine,Dopamine D2 receptor inhibitor
dopamine,Dopamine D1 receptor agonist
dopamine,Dopamine D1 receptor inhibitor
dopamine,Dopamine D5 receptor agonist
dopamine,Dopamine D3 receptor agonist
dopamine,Dopamine D3 receptor binder
dopamine,Dopamine D3 receptor inhibitor
dopamine,Dopamine D4 receptor agonist
dopamine,Sodium-dependent dopamine transporter agonist
dopamine,Sodium-dependent dopamine transporter binder
dopamine,Sodium-dependent dopamine transporter inhibitor
dopamine,5-hydroxytryptamine receptor 1A agonist
dopamine,5-hydroxytryptamine receptor 1A binder
dopamine,5-hydroxytryptamine receptor 1A inhibitor
dopamine,5-hydroxytryptamine receptor 7 agonist
dopamine,5-hydroxytryptamine receptor 7 binder
dopamine,5-hydroxytryptamine receptor 7 inhibitor
dopamine,D(1) dopamine receptor agonist
dopamine,D(1) dopamine receptor binder
dopamine,D(1) dopamine receptor inhibitor
dopamine,Sodium-dependent noradrenaline transporter agonist
dopamine,Sodium-dependent noradrenaline transporter binder
dopamine,Sodium-dependent noradrenaline transporter inhibitor
dopamine,Sodium-dependent serotonin transporter agonist
dopamine,Sodium-dependent serotonin transporter binder
dopamine,Sodium-dependent serotonin transporter inhibitor
dopamine,5-hydroxytryptamine receptor 3A agonist
dopamine,5-hydroxytryptamine receptor 3A binder
dopamine,5-hydroxytryptamine receptor 3A inhibitor
dopamine,Synaptic vesicular amine transporter inhibitor
rivastigmine,Acetylcholinesterase inhibitor
rivastigmine,Cholinesterase inhibitor
oxaprozin,Prostaglandin G/H synthase 1 inhibitor
oxaprozin,Prostaglandin G/H synthase 2 inhibitor
gabapentin,Voltage-dependent calcium channel subunit alpha-2/delta-1 inhibitor
gabapentin,Adenosine receptor A1 inhibitor
doxorubicin,DNA inhibitor
doxorubicin,DNA topoisomerase 2-alpha inhibitor
frovatriptan,5-hydroxytryptamine receptor 1D agonist
frovatriptan,5-hydroxytryptamine receptor 1B agonist
salbutamol,Beta-2 adrenergic receptor agonist
salbutamol,Beta-1 adrenergic receptor agonist
salbutamol,Beta-3 adrenergic receptor agonist
ganciclovir,DNA polymerase catalytic subunit inhibitor
ganciclovir,DNA inhibitor
ketoprofen,Prostaglandin G/H synthase 1 inhibitor
ketoprofen,Prostaglandin G/H synthase 2 inhibitor
edrophonium,Acetylcholinesterase inhibitor
edrophonium,Cholinesterase inhibitor
balsalazide,Peroxisome proliferator-activated receptor gamma agonist
balsalazide,Peroxisome proliferator-activated receptor gamma inhibitor
balsalazide,Prostaglandin G/H synthase 2 inhibitor
balsalazide,Prostaglandin G/H synthase 1 inhibitor
guanfacine,Alpha-2A adrenergic receptor agonist
guanfacine,Alpha-2A adrenergic receptor binder
guanfacine,Alpha-2B adrenergic receptor agonist
guanfacine,Alpha-2B adrenergic receptor binder
bethanechol,Muscarinic acetylcholine receptor M3 agonist
bethanechol,Muscarinic acetylcholine receptor M1 agonist
felodipine,Voltage-dependent L-type calcium channel subunit alpha-1C inhibitor
felodipine,Voltage-dependent calcium channel subunit alpha-2/delta-1 inhibitor
felodipine,Voltage-dependent L-type calcium channel subunit beta-2 inhibitor
felodipine,Voltage-dependent L-type calcium channel subunit alpha-1D inhibitor
felodipine,Voltage-dependent L-type calcium channel subunit alpha-1S inhibitor
felodipine,Calmodulin inhibitor
felodipine,Calmodulin antagonist
ketoconazole,Androgen receptor inhibitor
ketoconazole,Androgen receptor antagonist
ketoconazole,Potassium voltage-gated channel subfamily H member 2 inhibitor
ketoconazole,Potassium voltage-gated channel subfamily H member 2 binder
ketoconazole,Potassium voltage-gated channel subfamily H member 2 antagonist
ketoconazole,Nuclear receptor subfamily 1 group I member 2 inhibitor
irbesartan,Type-1 angiotensin II receptor antagonist
topotecan,DNA inhibitor
procainamide,Sodium channel protein type 5 subunit alpha inhibitor
procainamide,Potassium voltage-gated channel subfamily H member 2 inhibitor
tolterodine,Muscarinic acetylcholine receptor M3 antagonist
tolterodine,Muscarinic acetylcholine receptor M2 antagonist
tolterodine,Muscarinic acetylcholine receptor M5 antagonist
tolterodine,Muscarinic acetylcholine receptor M1 antagonist
tolterodine,Muscarinic acetylcholine receptor M4 antagonist
fenofibrate,Peroxisome proliferator-activated receptor alpha agonist
fenofibrate,Peroxisome proliferator-activated receptor alpha inhibitor
fenofibrate,Nuclear receptor subfamily 1 group I member 2 agonist
fenofibrate,Nuclear receptor subfamily 1 group I member 2 inhibitor
thalidomide,DNA inhibitor
thalidomide,Prostaglandin G/H synthase 2 inhibitor
memantine,5-hydroxytryptamine receptor 3A antagonist
memantine,5-hydroxytryptamine receptor 3A agonist
memantine,5-hydroxytryptamine receptor 3A binder
memantine,5-hydroxytryptamine receptor 3A inhibitor
memantine,Dopamine D2 receptor antagonist
memantine,Dopamine D2 receptor agonist
memantine,Dopamine D2 receptor binder
memantine,Dopamine D2 receptor inhibitor
memantine,GABA(A) Receptor antagonist
memantine,GABA(A) Receptor agonist
memantine,GABA(A) Receptor inhibitor
gatifloxacin,DNA gyrase subunit A inhibitor
gatifloxacin,DNA topoisomerase 4 subunit A inhibitor
abacavir,Reverse transcriptase/RNaseH inhibitor
ibuprofen,Prostaglandin G/H synthase 2 inhibitor
ibuprofen,Prostaglandin G/H synthase 1 inhibitor
ibuprofen,Peroxisome proliferator-activated receptor gamma inhibitor
ibuprofen,Peroxisome proliferator-activated receptor alpha inhibitor
norfloxacin,DNA topoisomerase 4 subunit A inhibitor
norfloxacin,DNA gyrase subunit A inhibitor
norfloxacin,DNA topoisomerase 2-alpha inhibitor
oxybutynin,Muscarinic acetylcholine receptor M3 antagonist
oxybutynin,Muscarinic acetylcholine receptor M2 antagonist
oxybutynin,Muscarinic acetylcholine receptor M1 antagonist
melatonin,Estrogen receptor alpha agonist
melatonin,Estrogen receptor alpha antagonist
melatonin,Estrogen receptor alpha inhibitor
melatonin,Calmodulin antagonist
melatonin,Calmodulin inhibitor
clonazepam,GABA(A) Receptor ligand
clonazepam,GABA(A) Receptor Benzodiazepine Binding Site ligand
promethazine,Histamine H1 receptor antagonist
promethazine,Histamine H1 receptor inhibitor
promethazine,Dopamine D2 receptor antagonist
promethazine,Dopamine D2 receptor inhibitor
promethazine,Muscarinic acetylcholine receptor M1 antagonist
promethazine,Muscarinic acetylcholine receptor M1 inhibitor
promethazine,Muscarinic acetylcholine receptor M2 antagonist
promethazine,Muscarinic acetylcholine receptor M2 inhibitor
promethazine,Muscarinic acetylcholine receptor M3 antagonist
promethazine,Muscarinic acetylcholine receptor M3 inhibitor
promethazine,Muscarinic acetylcholine receptor M4 antagonist
promethazine,Muscarinic acetylcholine receptor M4 inhibitor
promethazine,Muscarinic acetylcholine receptor M5 antagonist
promethazine,Muscarinic acetylcholine receptor M5 inhibitor
promethazine,Calmodulin antagonist
promethazine,Calmodulin inhibitor
promethazine,Histamine H2 receptor antagonist
atazanavir,Human immunodeficiency virus type 1 protease inhibitor
fludarabine,DNA inhibitor
diphenhydramine,Histamine H1 receptor antagonist
diphenhydramine,Muscarinic acetylcholine receptor M2 antagonist
tegaserod,5-hydroxytryptamine receptor 2B antagonist
tegaserod,5-hydroxytryptamine receptor 2C antagonist
tegaserod,5-hydroxytryptamine receptor 2A antagonist
emedastine,Histamine H1 receptor antagonist
pilocarpine,Muscarinic acetylcholine receptor M3 agonist
pilocarpine,Muscarinic acetylcholine receptor M1 agonist
fluvastatin,Histone deacetylase 2 inhibitor
pimozide,Dopamine D2 receptor antagonist
pimozide,Dopamine D2 receptor inhibitor
pimozide,Dopamine D3 receptor antagonist
pimozide,Dopamine D3 receptor inhibitor
pimozide,Potassium voltage-gated channel subfamily H member 2 antagonist
pimozide,Potassium voltage-gated channel subfamily H member 2 inhibitor
pimozide,Calmodulin antagonist
pimozide,Calmodulin inhibitor
capecitabine,Thymidylate synthase inhibitor
capecitabine,DNA inhibitor
sertraline,Sodium-dependent serotonin transporter inhibitor
sertraline,Sodium-dependent serotonin transporter binder
sertraline,Sodium-dependent dopamine transporter inhibitor
sertraline,Sodium-dependent dopamine transporter binder
sertraline,Sodium-dependent noradrenaline transporter inhibitor
sertraline,Sodium-dependent noradrenaline transporter binder
sibutramine,Sodium-dependent noradrenaline transporter inhibitor
sibutramine,Sodium-dependent serotonin transporter inhibitor
sibutramine,Sodium-dependent dopamine transporter inhibitor
chlorpheniramine,Histamine H1 receptor antagonist
chlorpheniramine,Histamine H1 receptor inhibitor
chlorpheniramine,Sodium-dependent serotonin transporter antagonist
chlorpheniramine,Sodium-dependent serotonin transporter inhibitor
chlorpheniramine,Sodium-dependent noradrenaline transporter antagonist
chlorpheniramine,Sodium-dependent noradrenaline transporter inhibitor
chlorpheniramine,Sodium-dependent dopamine transporter antagonist
chlorpheniramine,Sodium-dependent dopamine transporter inhibitor
nifedipine,Voltage-dependent L-type calcium channel subunit alpha-1C inhibitor
nifedipine,Nuclear receptor subfamily 1 group I member 2 inhibitor
nifedipine,Nuclear receptor subfamily 1 group I member 2 agonist
nifedipine,Calmodulin inhibitor
nifedipine,Voltage-dependent L-type calcium channel subunit alpha-1D inhibitor
nifedipine,Voltage-dependent L-type calcium channel subunit alpha-1S inhibitor
nifedipine,Voltage-dependent L-type calcium channel subunit beta-2 inhibitor
amiodarone,Beta adrenergic receptor inhibitor
amiodarone,Peroxisome proliferator-activated receptor gamma inhibitor
amiodarone,Peroxisome proliferator-activated receptor gamma agonist
amiodarone,Peroxisome proliferator-activated receptor alpha inhibitor
amiodarone,Peroxisome proliferator-activated receptor alpha agonist
diazoxide,Carbonic anhydrase 1 inhibitor
diazoxide,Carbonic anhydrase 2 inhibitor
bicalutamide,Androgen receptor antagonist
pioglitazone,Peroxisome proliferator-activated receptor gamma agonist
pioglitazone,Peroxisome proliferator-activated receptor gamma inhibitor
pioglitazone,Amine oxidase [flavin-containing] B inhibitor
carvedilol,Beta-1 adrenergic receptor antagonist
carvedilol,Beta-1 adrenergic receptor inhibitor
carvedilol,Alpha-1A adrenergic receptor antagonist
carvedilol,Alpha-1A adrenergic receptor inhibitor
carvedilol,Beta-2 adrenergic receptor antagonist
carvedilol,Beta-2 adrenergic receptor inhibitor
carvedilol,Potassium voltage-gated channel subfamily H member 2 antagonist
carvedilol,Potassium voltage-gated channel subfamily H member 2 inhibitor
carvedilol,Alpha-1D adrenergic receptor antagonist
carvedilol,Alpha-1D adrenergic receptor inhibitor
carvedilol,Alpha-1B adrenergic receptor antagonist
carvedilol,Alpha-1B adrenergic receptor inhibitor
carvedilol,Alpha-2C adrenergic receptor antagonist
carvedilol,Alpha-2C adrenergic receptor inhibitor
carvedilol,Alpha-2B adrenergic receptor antagonist
carvedilol,Alpha-2B adrenergic receptor inhibitor
carvedilol,Alpha-2A adrenergic receptor antagonist
carvedilol,Alpha-2A adrenergic receptor inhibitor
carvedilol,Alpha-1 adrenergic receptors antagonist
carvedilol,Alpha-1 adrenergic receptors inhibitor
doxepin,Histamine H1 receptor antagonist
doxepin,Histamine H1 receptor inhibitor
doxepin,Histamine H1 receptor binder
doxepin,Histamine H2 receptor antagonist
doxepin,Sodium-dependent noradrenaline transporter antagonist
doxepin,Sodium-dependent noradrenaline transporter inhibitor
doxepin,Sodium-dependent noradrenaline transporter binder
doxepin,Sodium-dependent serotonin transporter antagonist
doxepin,Sodium-dependent serotonin transporter inhibitor
doxepin,Sodium-dependent serotonin transporter binder
doxepin,5-hydroxytryptamine receptor 2A antagonist
doxepin,5-hydroxytryptamine receptor 2A inhibitor
doxepin,5-hydroxytryptamine receptor 2A binder
doxepin,5-hydroxytryptamine receptor 2B antagonist
doxepin,5-hydroxytryptamine receptor 2B inhibitor
doxepin,5-hydroxytryptamine receptor 2B binder
doxepin,5-hydroxytryptamine receptor 2C antagonist
doxepin,5-hydroxytryptamine receptor 2C inhibitor
doxepin,5-hydroxytryptamine receptor 2C binder
doxepin,Muscarinic acetylcholine receptor M1 antagonist
doxepin,Muscarinic acetylcholine receptor M1 inhibitor
doxepin,Muscarinic acetylcholine receptor M1 binder
doxepin,Muscarinic acetylcholine receptor M2 antagonist
doxepin,Muscarinic acetylcholine receptor M2 inhibitor
doxepin,Muscarinic acetylcholine receptor M3 antagonist
doxepin,Muscarinic acetylcholine receptor M3 inhibitor
doxepin,Muscarinic acetylcholine receptor M3 binder
doxepin,Muscarinic acetylcholine receptor M4 antagonist
doxepin,Muscarinic acetylcholine receptor M4 inhibitor
doxepin,Muscarinic acetylcholine receptor M5 antagonist
doxepin,Muscarinic acetylcholine receptor M5 inhibitor
doxepin,Alpha-1A adrenergic receptor antagonist
doxepin,Alpha-1A adrenergic receptor inhibitor
doxepin,Alpha-1A adrenergic receptor binder
doxepin,Alpha-1B adrenergic receptor antagonist
doxepin,Alpha-1B adrenergic receptor inhibitor
doxepin,Alpha-1B adrenergic receptor binder
doxepin,Alpha-1D adrenergic receptor antagonist
doxepin,Alpha-1D adrenergic receptor inhibitor
doxepin,Alpha-1D adrenergic receptor binder
doxepin,5-hydroxytryptamine receptor 1A antagonist
doxepin,5-hydroxytryptamine receptor 1A inhibitor
doxepin,5-hydroxytryptamine receptor 1A binder
doxepin,5-hydroxytryptamine receptor 6 antagonist
doxepin,5-hydroxytryptamine receptor 6 inhibitor
doxepin,5-hydroxytryptamine receptor 6 binder
doxepin,Histamine H4 receptor antagonist
doxepin,Histamine H4 receptor binder
doxepin,Potassium voltage-gated channel subfamily H member 2 antagonist
doxepin,Potassium voltage-gated channel subfamily H member 2 inhibitor
doxepin,Potassium voltage-gated channel subfamily H member 2 binder
flavoxate,Muscarinic acetylcholine receptor M2 antagonist
flavoxate,Muscarinic acetylcholine receptor M1 antagonist
nefazodone,5-hydroxytryptamine receptor 2A antagonist
nefazodone,5-hydroxytryptamine receptor 2A inhibitor
nefazodone,5-hydroxytryptamine receptor 2A other/unknown
nefazodone,5-hydroxytryptamine receptor 2C antagonist
nefazodone,5-hydroxytryptamine receptor 2C inhibitor
nefazodone,Sodium-dependent serotonin transporter antagonist
nefazodone,Sodium-dependent serotonin transporter inhibitor
nefazodone,5-hydroxytryptamine receptor 1A antagonist
nefazodone,5-hydroxytryptamine receptor 1A inhibitor
nefazodone,5-hydroxytryptamine receptor 1A other/unknown
nefazodone,Sodium-dependent noradrenaline transporter antagonist
nefazodone,Sodium-dependent noradrenaline transporter inhibitor
nefazodone,Sodium-dependent dopamine transporter antagonist
nefazodone,Sodium-dependent dopamine transporter inhibitor
nefazodone,Alpha-1B adrenergic receptor antagonist
nefazodone,Alpha-1B adrenergic receptor inhibitor
nefazodone,Alpha-2A adrenergic receptor antagonist
nefazodone,Alpha-2A adrenergic receptor inhibitor
nefazodone,Alpha-1A adrenergic receptor antagonist
nefazodone,Alpha-1A adrenergic receptor inhibitor
nefazodone,Potassium voltage-gated channel subfamily H member 2 antagonist
nefazodone,Potassium voltage-gated channel subfamily H member 2 inhibitor
desipramine,Sodium-dependent noradrenaline transporter inhibitor
desipramine,Sodium-dependent noradrenaline transporter antagonist
desipramine,Sodium-dependent noradrenaline transporter binder
desipramine,Beta-2 adrenergic receptor inhibitor
desipramine,Beta-2 adrenergic receptor antagonist
desipramine,Sodium-dependent serotonin transporter inhibitor
desipramine,Sodium-dependent serotonin transporter antagonist
desipramine,Sodium-dependent serotonin transporter binder
desipramine,5-hydroxytryptamine receptor 2A inhibitor
desipramine,5-hydroxytryptamine receptor 2A antagonist
desipramine,5-hydroxytryptamine receptor 2A binder
desipramine,Beta-1 adrenergic receptor inhibitor
desipramine,Beta-1 adrenergic receptor antagonist
desipramine,Histamine H1 receptor inhibitor
desipramine,Histamine H1 receptor antagonist
desipramine,Histamine H1 receptor binder
desipramine,Alpha-1 adrenergic receptors inhibitor
desipramine,Alpha-1 adrenergic receptors antagonist
desipramine,Alpha-1 adrenergic receptors binder
desipramine,Muscarinic acetylcholine receptor M1 inhibitor
desipramine,Muscarinic acetylcholine receptor M1 antagonist
desipramine,Muscarinic acetylcholine receptor M1 binder
desipramine,Muscarinic acetylcholine receptor M2 inhibitor
desipramine,Muscarinic acetylcholine receptor M2 antagonist
desipramine,Muscarinic acetylcholine receptor M3 inhibitor
desipramine,Muscarinic acetylcholine receptor M3 antagonist
desipramine,Muscarinic acetylcholine receptor M3 binder
desipramine,Muscarinic acetylcholine receptor M4 inhibitor
desipramine,Muscarinic acetylcholine receptor M4 antagonist
desipramine,Muscarinic acetylcholine receptor M5 inhibitor
desipramine,Muscarinic acetylcholine receptor M5 antagonist
desipramine,5-hydroxytryptamine receptor 1A inhibitor
desipramine,5-hydroxytryptamine receptor 1A antagonist
desipramine,5-hydroxytryptamine receptor 1A binder
desipramine,5-hydroxytryptamine receptor 2C inhibitor
desipramine,5-hydroxytryptamine receptor 2C antagonist
desipramine,5-hydroxytryptamine receptor 2C binder
desipramine,Dopamine D2 receptor inhibitor
desipramine,Dopamine D2 receptor antagonist
desipramine,Dopamine D2 receptor binder
desipramine,Alpha-2 adrenergic receptors inhibitor
desipramine,Alpha-2 adrenergic receptors antagonist
desipramine,Alpha-2 adrenergic receptors binder
gemifloxacin,DNA topoisomerase 4 subunit A inhibitor
gemifloxacin,DNA gyrase subunit A inhibitor
bupropion,Sodium-dependent dopamine transporter inhibitor
bupropion,Sodium-dependent dopamine transporter antagonist
bupropion,Sodium-dependent noradrenaline transporter inhibitor
bupropion,Sodium-dependent noradrenaline transporter antagonist
bupropion,5-hydroxytryptamine receptor 3A inhibitor
bupropion,5-hydroxytryptamine receptor 3A antagonist
chloroprocaine,Sodium channel protein type 10 subunit alpha inhibitor
chloroprocaine,Sodium-dependent dopamine transporter inhibitor
terazosin,Alpha-1A adrenergic receptor antagonist
terazosin,Alpha-1A adrenergic receptor inhibitor
terazosin,Alpha-1B adrenergic receptor antagonist
terazosin,Alpha-1B adrenergic receptor inhibitor
terazosin,Alpha-1D adrenergic receptor antagonist
terazosin,Alpha-1D adrenergic receptor inhibitor
terazosin,Potassium voltage-gated channel subfamily H member 2 antagonist
terazosin,Potassium voltage-gated channel subfamily H member 2 inhibitor
ofloxacin,DNA topoisomerase 4 subunit A inhibitor
ofloxacin,DNA gyrase subunit A inhibitor
ofloxacin,DNA topoisomerase 2-alpha inhibitor
cilostazol,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A inhibitor"
procarbazine,DNA inhibitor
moclobemide,Amine oxidase [flavin-containing] B inhibitor
orphenadrine,Histamine H1 receptor antagonist
orphenadrine,Histamine H1 receptor inhibitor
orphenadrine,Sodium-dependent noradrenaline transporter antagonist
orphenadrine,Sodium-dependent noradrenaline transporter inhibitor
orphenadrine,Sodium channel protein type 10 subunit alpha inhibitor
phenobarbital,Gamma-aminobutyric acid receptor subunit alpha-1 potentiator
phenobarbital,Gamma-aminobutyric acid receptor subunit alpha-1 antagonist
phenobarbital,Neuronal acetylcholine receptor subunit alpha-4 antagonist
phenobarbital,Neuronal acetylcholine receptor subunit alpha-7 antagonist
cyclizine,Histamine H1 receptor antagonist
cyclizine,Histamine H1 receptor inhibitor
idarubicin,DNA inhibitor
idarubicin,DNA topoisomerase 2-alpha inhibitor
rescinnamine,Angiotensin-converting enzyme inhibitor
propafenone,Sodium channel protein type 5 subunit alpha inhibitor
propafenone,Potassium voltage-gated channel subfamily H member 2 inhibitor
propafenone,Potassium voltage-gated channel subfamily H member 2 antagonist
propafenone,Beta-1 adrenergic receptor inhibitor
propafenone,Beta-1 adrenergic receptor antagonist
propafenone,Beta-2 adrenergic receptor inhibitor
propafenone,Beta-2 adrenergic receptor antagonist
naloxone,Mu-type opioid receptor antagonist
naloxone,Mu-type opioid receptor inhibitor
naloxone,Delta-type opioid receptor antagonist
naloxone,Kappa-type opioid receptor antagonist
naloxone,Kappa-type opioid receptor inhibitor
naloxone,Kappa-type opioid receptor binder
naloxone,Estrogen receptor alpha antagonist
naloxone,Estrogen receptor alpha inhibitor
pergolide,Dopamine D2 receptor agonist
pergolide,Dopamine D3 receptor agonist
pergolide,Dopamine D4 receptor agonist
pergolide,5-hydroxytryptamine receptor 1A agonist
pergolide,5-hydroxytryptamine receptor 2B agonist
pergolide,5-hydroxytryptamine receptor 2A agonist
pergolide,5-hydroxytryptamine receptor 1D agonist
pergolide,Alpha-2 adrenergic receptors agonist
pergolide,Dopamine D5 receptor agonist
pergolide,Dopamine D1 receptor agonist
pergolide,5-hydroxytryptamine receptor 1B agonist
pergolide,5-hydroxytryptamine receptor 2C agonist
pergolide,Alpha-1A adrenergic receptor agonist
pergolide,Alpha-1B adrenergic receptor agonist
pergolide,Alpha-1D adrenergic receptor agonist
desflurane,GABA(A) Receptor agonist
desflurane,GABA(A) Receptor antagonist
desflurane,GABA(A) Receptor inhibitor
oxymorphone,Mu-type opioid receptor agonist
oxymorphone,Mu-type opioid receptor antagonist
oxymorphone,Delta-type opioid receptor agonist
oxymorphone,Delta-type opioid receptor antagonist
acebutolol,Beta-1 adrenergic receptor partial agonist
acebutolol,Beta-2 adrenergic receptor partial agonist
brinzolamide,Carbonic anhydrase 2 inhibitor
brinzolamide,Carbonic anhydrase 1 inhibitor
brinzolamide,Carbonic anhydrase 3 inhibitor
flecainide,Sodium channel protein type 5 subunit alpha inhibitor
flecainide,Potassium voltage-gated channel subfamily H member 2 inhibitor
estramustine,Estrogen receptor alpha antagonist
estramustine,Estrogen receptor alpha agonist
estramustine,Estrogen receptor beta agonist
captopril,Angiotensin-converting enzyme inhibitor
zopiclone,Gamma-aminobutyric acid receptor subunit alpha-1 potentiator
zopiclone,Gamma-aminobutyric acid receptor subunit alpha-1 agonist
bromocriptine,Dopamine D2 receptor agonist
bromocriptine,Dopamine D2 receptor antagonist
bromocriptine,Dopamine D3 receptor agonist
bromocriptine,Dopamine D3 receptor antagonist
bromocriptine,5-hydroxytryptamine receptor 1D agonist
bromocriptine,5-hydroxytryptamine receptor 1D antagonist
bromocriptine,Alpha-2A adrenergic receptor agonist
bromocriptine,Alpha-2A adrenergic receptor antagonist
bromocriptine,5-hydroxytryptamine receptor 1A agonist
bromocriptine,5-hydroxytryptamine receptor 1A antagonist
bromocriptine,Alpha-2C adrenergic receptor agonist
bromocriptine,Alpha-2C adrenergic receptor antagonist
bromocriptine,Alpha-2B adrenergic receptor agonist
bromocriptine,Alpha-2B adrenergic receptor antagonist
bromocriptine,5-hydroxytryptamine receptor 2B agonist
bromocriptine,5-hydroxytryptamine receptor 2B antagonist
bromocriptine,Dopamine D4 receptor agonist
bromocriptine,Dopamine D4 receptor antagonist
bromocriptine,5-hydroxytryptamine receptor 2A agonist
bromocriptine,5-hydroxytryptamine receptor 2A antagonist
bromocriptine,5-hydroxytryptamine receptor 1B agonist
bromocriptine,5-hydroxytryptamine receptor 1B antagonist
bromocriptine,5-hydroxytryptamine receptor 2C agonist
bromocriptine,5-hydroxytryptamine receptor 2C antagonist
bromocriptine,Dopamine D5 receptor agonist
bromocriptine,Dopamine D5 receptor antagonist
bromocriptine,Dopamine D1 receptor agonist
bromocriptine,Dopamine D1 receptor antagonist
bromocriptine,Alpha-1A adrenergic receptor agonist
bromocriptine,Alpha-1A adrenergic receptor antagonist
bromocriptine,Alpha-1B adrenergic receptor agonist
bromocriptine,Alpha-1B adrenergic receptor antagonist
bromocriptine,Alpha-1D adrenergic receptor agonist
bromocriptine,Alpha-1D adrenergic receptor antagonist
bromocriptine,5-hydroxytryptamine receptor 7 agonist
bromocriptine,5-hydroxytryptamine receptor 7 antagonist
nadolol,Beta-1 adrenergic receptor antagonist
nadolol,Beta-2 adrenergic receptor antagonist
mitoxantrone,DNA inhibitor
mitoxantrone,DNA topoisomerase 2-alpha inhibitor
flumazenil,Gamma-aminobutyric acid receptor subunit alpha-1 antagonist
flumazenil,GABA(A) Receptor antagonist
sparfloxacin,DNA topoisomerase 4 subunit A inhibitor
sparfloxacin,DNA gyrase subunit A inhibitor
sparfloxacin,DNA topoisomerase 2-alpha inhibitor
levobunolol,Beta-2 adrenergic receptor antagonist
levobunolol,Beta-1 adrenergic receptor antagonist
clarithromycin,Potassium voltage-gated channel subfamily H member 2 inhibitor
metipranolol,Beta-2 adrenergic receptor antagonist
metipranolol,Beta-1 adrenergic receptor antagonist
ketamine,Dopamine D2 receptor antagonist
ketamine,Dopamine D2 receptor agonist
ketamine,Dopamine D2 receptor binder
ketamine,Dopamine D2 receptor inhibitor
ketamine,Delta-type opioid receptor antagonist
ketamine,Delta-type opioid receptor agonist
ketamine,Sodium-dependent noradrenaline transporter antagonist
ketamine,Sodium-dependent noradrenaline transporter agonist
ketamine,Sodium-dependent noradrenaline transporter binder
ketamine,Sodium-dependent noradrenaline transporter inhibitor
ketamine,Kappa-type opioid receptor antagonist
ketamine,Kappa-type opioid receptor agonist
ketamine,Kappa-type opioid receptor partial agonist
ketamine,Kappa-type opioid receptor binder
ketamine,Kappa-type opioid receptor inhibitor
ketamine,Mu-type opioid receptor antagonist
ketamine,Mu-type opioid receptor agonist
ketamine,Mu-type opioid receptor inhibitor
ketamine,Muscarinic acetylcholine receptor antagonist
ketamine,Muscarinic acetylcholine receptor binder
ketamine,Muscarinic acetylcholine receptor inhibitor
ketamine,5-hydroxytryptamine receptor 3A antagonist
ketamine,5-hydroxytryptamine receptor 3A agonist
ketamine,5-hydroxytryptamine receptor 3A binder
ketamine,5-hydroxytryptamine receptor 3A inhibitor
ketamine,Cholinesterase inhibitor
budesonide,Glucocorticoid receptor agonist
aminophylline,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A inhibitor"
aminophylline,Adenosine receptor A1 inhibitor
aminophylline,Adenosine receptor A1 antagonist
aminophylline,Histone deacetylase 2 inhibitor
quetiapine,5-hydroxytryptamine receptor 2A antagonist
quetiapine,Dopamine D2 receptor antagonist
quetiapine,5-hydroxytryptamine receptor 1A antagonist
quetiapine,5-hydroxytryptamine receptor 1A partial agonist
quetiapine,5-hydroxytryptamine receptor 1B antagonist
quetiapine,5-hydroxytryptamine receptor 1D antagonist
quetiapine,5-hydroxytryptamine receptor 1E antagonist
quetiapine,5-hydroxytryptamine receptor 2C antagonist
quetiapine,5-hydroxytryptamine receptor 3A antagonist
quetiapine,5-hydroxytryptamine receptor 6 antagonist
quetiapine,5-hydroxytryptamine receptor 7 antagonist
quetiapine,Dopamine D1 receptor antagonist
quetiapine,Dopamine D5 receptor antagonist
quetiapine,Dopamine D3 receptor antagonist
quetiapine,Dopamine D4 receptor antagonist
quetiapine,Histamine H1 receptor antagonist
quetiapine,Alpha-1 adrenergic receptors antagonist
quetiapine,Alpha-2A adrenergic receptor antagonist
quetiapine,Alpha-2B adrenergic receptor antagonist
quetiapine,Alpha-2C adrenergic receptor antagonist
quetiapine,Muscarinic acetylcholine receptor M1 antagonist
quetiapine,Muscarinic acetylcholine receptor M2 antagonist
quetiapine,Muscarinic acetylcholine receptor M3 antagonist
quetiapine,Muscarinic acetylcholine receptor M4 antagonist
quetiapine,Muscarinic acetylcholine receptor M5 antagonist
mivacurium,Neuronal acetylcholine receptor subunit alpha-2 antagonist
mivacurium,Muscarinic acetylcholine receptor M2 antagonist
mivacurium,Muscarinic acetylcholine receptor M3 antagonist
paclitaxel,Nuclear receptor subfamily 1 group I member 2 inhibitor
saquinavir,Human immunodeficiency virus type 1 protease inhibitor
metoclopramide,Dopamine D2 receptor antagonist
metoclopramide,Dopamine D2 receptor agonist
metoclopramide,Muscarinic acetylcholine receptor M1 antagonist
metoclopramide,Muscarinic acetylcholine receptor M1 agonist
metoclopramide,5-hydroxytryptamine receptor 3A antagonist
metoclopramide,5-hydroxytryptamine receptor 3A agonist
dexamethasone,Glucocorticoid receptor agonist
dexamethasone,Nuclear receptor subfamily 1 group I member 2 agonist
sevoflurane,Gamma-aminobutyric acid receptor subunit alpha-1 agonist
sevoflurane,Gamma-aminobutyric acid receptor subunit alpha-1 antagonist
sevoflurane,GABA(A) Receptor agonist
sevoflurane,GABA(A) Receptor antagonist
sevoflurane,GABA(A) Receptor inhibitor
aripiprazole,5-hydroxytryptamine receptor 1A partial agonist
aripiprazole,5-hydroxytryptamine receptor 1A antagonist
aripiprazole,5-hydroxytryptamine receptor 1A other/unknown
aripiprazole,Dopamine D2 receptor antagonist
aripiprazole,Dopamine D2 receptor other/unknown
aripiprazole,5-hydroxytryptamine receptor 2A antagonist
aripiprazole,5-hydroxytryptamine receptor 2A other/unknown
aripiprazole,Alpha-1A adrenergic receptor antagonist
aripiprazole,Alpha-1B adrenergic receptor antagonist
aripiprazole,Dopamine D3 receptor antagonist
aripiprazole,5-hydroxytryptamine receptor 1D antagonist
aripiprazole,5-hydroxytryptamine receptor 7 antagonist
aripiprazole,Alpha-2A adrenergic receptor antagonist
aripiprazole,Alpha-2C adrenergic receptor antagonist
aripiprazole,Histamine H1 receptor antagonist
aripiprazole,5-hydroxytryptamine receptor 1B antagonist
aripiprazole,5-hydroxytryptamine receptor 2C antagonist
aripiprazole,5-hydroxytryptamine receptor 3A antagonist
aripiprazole,5-hydroxytryptamine receptor 6 antagonist
aripiprazole,Dopamine D1 receptor antagonist
aripiprazole,Dopamine D4 receptor antagonist
aripiprazole,Alpha-2B adrenergic receptor antagonist
aripiprazole,5-hydroxytryptamine receptor 1E antagonist
aripiprazole,Dopamine D5 receptor antagonist
aripiprazole,5-hydroxytryptamine receptor 2B antagonist
aripiprazole,Beta-1 adrenergic receptor partial agonist
aripiprazole,Beta-1 adrenergic receptor antagonist
aripiprazole,Beta-2 adrenergic receptor partial agonist
aripiprazole,Beta-2 adrenergic receptor antagonist
aripiprazole,Histamine H2 receptor antagonist
aripiprazole,Histamine H4 receptor antagonist
aripiprazole,Muscarinic acetylcholine receptor M1 antagonist
aripiprazole,Muscarinic acetylcholine receptor M2 antagonist
aripiprazole,Muscarinic acetylcholine receptor M3 antagonist
aripiprazole,Muscarinic acetylcholine receptor M4 antagonist
aripiprazole,Muscarinic acetylcholine receptor M5 antagonist
aripiprazole,Kappa-type opioid receptor partial agonist
aripiprazole,Kappa-type opioid receptor antagonist
aripiprazole,Mu-type opioid receptor antagonist
aripiprazole,Delta-type opioid receptor antagonist
aripiprazole,Sodium-dependent dopamine transporter antagonist
aripiprazole,Sodium-dependent serotonin transporter antagonist
clomipramine,Sodium-dependent serotonin transporter inhibitor
clomipramine,Sodium-dependent serotonin transporter antagonist
clomipramine,5-hydroxytryptamine receptor 2A inhibitor
clomipramine,5-hydroxytryptamine receptor 2A antagonist
clomipramine,5-hydroxytryptamine receptor 2B inhibitor
clomipramine,5-hydroxytryptamine receptor 2B antagonist
clomipramine,5-hydroxytryptamine receptor 2C inhibitor
clomipramine,5-hydroxytryptamine receptor 2C antagonist
clomipramine,Sodium-dependent noradrenaline transporter inhibitor
clomipramine,Sodium-dependent noradrenaline transporter antagonist
bepridil,Calmodulin inhibitor
bepridil,Potassium voltage-gated channel subfamily H member 2 inhibitor
bepridil,Potassium voltage-gated channel subfamily H member 2 binder
dasatinib,Tyrosine-protein kinase ABL1 inhibitor
dasatinib,Mast/stem cell growth factor receptor Kit inhibitor
dasatinib,Platelet-derived growth factor receptor beta inhibitor
darunavir,Human immunodeficiency virus type 1 protease inhibitor
paliperidone,5-hydroxytryptamine receptor 2A antagonist
paliperidone,5-hydroxytryptamine receptor 2A agonist
paliperidone,Dopamine D2 receptor antagonist
paliperidone,Dopamine D2 receptor agonist
paliperidone,Histamine H1 receptor antagonist
paliperidone,Histamine H1 receptor agonist
paliperidone,Alpha-1A adrenergic receptor antagonist
paliperidone,Alpha-1A adrenergic receptor agonist
paliperidone,Alpha-1B adrenergic receptor antagonist
paliperidone,Alpha-1B adrenergic receptor agonist
paliperidone,Dopamine D4 receptor antagonist
paliperidone,Dopamine D4 receptor agonist
paliperidone,5-hydroxytryptamine receptor 1D antagonist
paliperidone,5-hydroxytryptamine receptor 1D agonist
paliperidone,Dopamine D3 receptor antagonist
paliperidone,Dopamine D3 receptor agonist
paliperidone,5-hydroxytryptamine receptor 2C antagonist
paliperidone,5-hydroxytryptamine receptor 2C agonist
paliperidone,Alpha-2A adrenergic receptor antagonist
paliperidone,Alpha-2A adrenergic receptor agonist
paliperidone,Alpha-2B adrenergic receptor antagonist
paliperidone,Alpha-2B adrenergic receptor agonist
paliperidone,Alpha-2C adrenergic receptor antagonist
paliperidone,Alpha-2C adrenergic receptor agonist
paliperidone,5-hydroxytryptamine receptor 1A antagonist
paliperidone,5-hydroxytryptamine receptor 1A agonist
paliperidone,Dopamine D1 receptor antagonist
paliperidone,Dopamine D1 receptor agonist
paliperidone,5-hydroxytryptamine receptor 7 antagonist
paliperidone,5-hydroxytryptamine receptor 7 agonist
sunitinib,Platelet-derived growth factor receptor beta inhibitor
sunitinib,Mast/stem cell growth factor receptor Kit inhibitor
sunitinib,Vascular endothelial growth factor receptor 2 inhibitor
varenicline,Neuronal acetylcholine receptor subunit alpha-4 agonist
nelarabine,DNA inhibitor
pirbuterol,Beta-2 adrenergic receptor agonist
pirbuterol,Beta-1 adrenergic receptor agonist
fosamprenavir,Human immunodeficiency virus type 1 protease inhibitor
fosphenytoin,Sodium channel protein type 5 subunit alpha inhibitor
pancuronium,Neuronal acetylcholine receptor subunit alpha-2 antagonist
pancuronium,Muscarinic acetylcholine receptor M2 antagonist
pancuronium,Muscarinic acetylcholine receptor M3 antagonist
vecuronium,Neuronal acetylcholine receptor subunit alpha-2 antagonist
cilazapril,Angiotensin-converting enzyme inhibitor
amobarbital,Gamma-aminobutyric acid receptor subunit alpha-1 potentiator
amobarbital,Gamma-aminobutyric acid receptor subunit alpha-1 antagonist
amobarbital,Neuronal acetylcholine receptor subunit alpha-4 antagonist
amobarbital,Neuronal acetylcholine receptor subunit alpha-7 antagonist
penbutolol,Beta-1 adrenergic receptor antagonist
penbutolol,Beta-1 adrenergic receptor partial agonist
penbutolol,Beta-2 adrenergic receptor antagonist
penbutolol,Beta-2 adrenergic receptor partial agonist
penbutolol,5-hydroxytryptamine receptor 1A antagonist
penbutolol,5-hydroxytryptamine receptor 1A partial agonist
penbutolol,5-hydroxytryptamine receptor 1B antagonist
ephedrine,Sodium-dependent noradrenaline transporter agonist
ephedrine,Alpha-1A adrenergic receptor agonist
ephedrine,Beta-1 adrenergic receptor agonist
ephedrine,Beta-2 adrenergic receptor agonist
rasagiline,Amine oxidase [flavin-containing] B inhibitor
bezafibrate,Peroxisome proliferator-activated receptor alpha agonist
bezafibrate,Peroxisome proliferator-activated receptor gamma agonist
bezafibrate,Nuclear receptor subfamily 1 group I member 2 agonist
drospirenone,Androgen receptor agonist
drospirenone,Androgen receptor antagonist
drospirenone,Glucocorticoid receptor agonist
neostigmine,Acetylcholinesterase inhibitor
danazol,Estrogen receptor alpha agonist
danazol,Estrogen receptor alpha inhibitor
danazol,Androgen receptor agonist
danazol,Androgen receptor inhibitor
tiotropium,Muscarinic acetylcholine receptor M3 antagonist
tiotropium,Muscarinic acetylcholine receptor M1 antagonist
tiotropium,Muscarinic acetylcholine receptor M2 antagonist
tiotropium,Muscarinic acetylcholine receptor M4 antagonist
tiotropium,Muscarinic acetylcholine receptor M5 antagonist
flunitrazepam,GABA(A) Receptor ligand
flunitrazepam,GABA(A) Receptor Benzodiazepine Binding Site ligand
bromazepam,GABA(A) Receptor ligand
bromazepam,GABA(A) Receptor Benzodiazepine Binding Site ligand
phendimetrazine,Alpha-1A adrenergic receptor agonist
phendimetrazine,Sodium-dependent noradrenaline transporter agonist
phendimetrazine,Alpha-1B adrenergic receptor agonist
oxprenolol,Beta-1 adrenergic receptor antagonist
oxprenolol,Beta-2 adrenergic receptor antagonist
oxprenolol,Beta-3 adrenergic receptor antagonist
solifenacin,Muscarinic acetylcholine receptor M3 antagonist
solifenacin,Muscarinic acetylcholine receptor M1 antagonist
solifenacin,Muscarinic acetylcholine receptor M2 antagonist
solifenacin,Muscarinic acetylcholine receptor M4 antagonist
solifenacin,Muscarinic acetylcholine receptor M5 antagonist
molindone,Dopamine D2 receptor antagonist
molindone,Dopamine D2 receptor other/unknown
molindone,5-hydroxytryptamine receptor 1A antagonist
molindone,5-hydroxytryptamine receptor 1A other/unknown
molindone,5-hydroxytryptamine receptor 2A antagonist
molindone,5-hydroxytryptamine receptor 2A other/unknown
molindone,Muscarinic acetylcholine receptor M1 antagonist
thiothixene,Dopamine D2 receptor antagonist
thiothixene,Dopamine D1 receptor antagonist
thiothixene,5-hydroxytryptamine receptor 2A antagonist
zuclopenthixol,Dopamine D1 receptor antagonist
zuclopenthixol,Dopamine D5 receptor antagonist
zuclopenthixol,Dopamine D2 receptor antagonist
zuclopenthixol,Alpha-1A adrenergic receptor antagonist
zuclopenthixol,Alpha-2A adrenergic receptor antagonist
zuclopenthixol,5-hydroxytryptamine receptor 2A antagonist
zuclopenthixol,Histamine H1 receptor antagonist
etoricoxib,Prostaglandin G/H synthase 2 inhibitor
vorinostat,Histone deacetylase 2 inhibitor
estriol,Estrogen receptor alpha agonist
estriol,Estrogen receptor beta agonist
tetrabenazine,Synaptic vesicular amine transporter inhibitor
tetrabenazine,Dopamine D2 receptor inhibitor
celiprolol,Beta-1 adrenergic receptor antagonist
celiprolol,Beta-1 adrenergic receptor agonist
celiprolol,Beta-2 adrenergic receptor antagonist
celiprolol,Beta-2 adrenergic receptor agonist
celiprolol,Beta-3 adrenergic receptor antagonist
celiprolol,Beta-3 adrenergic receptor agonist
celiprolol,Alpha-2A adrenergic receptor antagonist
celiprolol,Alpha-2A adrenergic receptor agonist
celiprolol,Alpha-2B adrenergic receptor antagonist
celiprolol,Alpha-2B adrenergic receptor agonist
celiprolol,Alpha-2C adrenergic receptor antagonist
celiprolol,Alpha-2C adrenergic receptor agonist
dronedarone,Alpha-1A adrenergic receptor antagonist
dronedarone,Alpha-1A adrenergic receptor inhibitor
dronedarone,Alpha-1B adrenergic receptor antagonist
dronedarone,Alpha-1B adrenergic receptor inhibitor
dronedarone,Alpha-1D adrenergic receptor antagonist
dronedarone,Alpha-1D adrenergic receptor inhibitor
dronedarone,Alpha-2A adrenergic receptor antagonist
dronedarone,Alpha-2A adrenergic receptor inhibitor
dronedarone,Alpha-2B adrenergic receptor antagonist
dronedarone,Alpha-2B adrenergic receptor inhibitor
dronedarone,Alpha-2C adrenergic receptor antagonist
dronedarone,Alpha-2C adrenergic receptor inhibitor
dronedarone,Beta-1 adrenergic receptor antagonist
dronedarone,Beta-1 adrenergic receptor inhibitor
dronedarone,Potassium voltage-gated channel subfamily H member 2 antagonist
dronedarone,Potassium voltage-gated channel subfamily H member 2 inhibitor
dronedarone,Voltage-dependent L-type calcium channel subunit alpha-1C inhibitor
dronedarone,Voltage-dependent L-type calcium channel subunit alpha-1D inhibitor
dronedarone,Voltage-dependent L-type calcium channel subunit alpha-1S inhibitor
dronedarone,Voltage-dependent L-type calcium channel subunit beta-2 inhibitor
dronedarone,Sodium channel protein type 5 subunit alpha inhibitor
nebivolol,Beta-1 adrenergic receptor antagonist
nebivolol,Beta-1 adrenergic receptor agonist
nebivolol,Beta-2 adrenergic receptor antagonist
nebivolol,Beta-2 adrenergic receptor agonist
nebivolol,Beta-3 adrenergic receptor antagonist
nebivolol,Beta-3 adrenergic receptor agonist
nilotinib,Tyrosine-protein kinase ABL1 inhibitor
nilotinib,Mast/stem cell growth factor receptor Kit inhibitor
milnacipran,Sodium-dependent serotonin transporter inhibitor
milnacipran,Sodium-dependent noradrenaline transporter inhibitor
ospemifene,Estrogen receptor alpha antagonist
ospemifene,Estrogen receptor alpha agonist
iloperidone,5-hydroxytryptamine receptor 2A antagonist
iloperidone,Dopamine D2 receptor antagonist
iloperidone,Dopamine D1 receptor antagonist
iloperidone,Dopamine D3 receptor antagonist
iloperidone,Dopamine D4 receptor antagonist
iloperidone,5-hydroxytryptamine receptor 1A antagonist
iloperidone,5-hydroxytryptamine receptor 6 antagonist
iloperidone,5-hydroxytryptamine receptor 7 antagonist
iloperidone,Alpha-1A adrenergic receptor antagonist
iloperidone,Histamine H1 receptor antagonist
iloperidone,Alpha-2C adrenergic receptor antagonist
indacaterol,Beta-2 adrenergic receptor agonist
rotigotine,Dopamine D3 receptor agonist
rotigotine,Dopamine D3 receptor antagonist
rotigotine,Dopamine D4 receptor agonist
rotigotine,Dopamine D4 receptor antagonist
rotigotine,Dopamine D5 receptor agonist
rotigotine,Dopamine D5 receptor antagonist
rotigotine,Dopamine D2 receptor agonist
rotigotine,Dopamine D2 receptor antagonist
rotigotine,Dopamine D1 receptor agonist
rotigotine,Dopamine D1 receptor antagonist
rotigotine,5-hydroxytryptamine receptor 1A agonist
rotigotine,5-hydroxytryptamine receptor 1A antagonist
rotigotine,Alpha-2B adrenergic receptor agonist
rotigotine,Alpha-2B adrenergic receptor antagonist
histamine,Histamine H1 receptor agonist
mianserin,Alpha-2A adrenergic receptor antagonist
mianserin,Alpha-2A adrenergic receptor inhibitor
mianserin,Alpha-2A adrenergic receptor binder
mianserin,Alpha-2A adrenergic receptor agonist
mianserin,5-hydroxytryptamine receptor 2A antagonist
mianserin,5-hydroxytryptamine receptor 2A inhibitor
mianserin,5-hydroxytryptamine receptor 2A binder
mianserin,5-hydroxytryptamine receptor 2A agonist
mianserin,5-hydroxytryptamine receptor 2C antagonist
mianserin,5-hydroxytryptamine receptor 2C inhibitor
mianserin,5-hydroxytryptamine receptor 2C binder
mianserin,5-hydroxytryptamine receptor 2C agonist
mianserin,Histamine H1 receptor antagonist
mianserin,Histamine H1 receptor inhibitor
mianserin,Histamine H1 receptor binder
mianserin,Histamine H1 receptor agonist
mianserin,Sodium-dependent noradrenaline transporter antagonist
mianserin,Sodium-dependent noradrenaline transporter inhibitor
mianserin,Sodium-dependent noradrenaline transporter binder
mianserin,Sodium-dependent noradrenaline transporter agonist
mianserin,Sodium-dependent serotonin transporter antagonist
mianserin,Sodium-dependent serotonin transporter inhibitor
mianserin,Sodium-dependent serotonin transporter binder
mianserin,Sodium-dependent serotonin transporter agonist
mianserin,Histamine H4 receptor antagonist
mianserin,Histamine H4 receptor binder
mianserin,5-hydroxytryptamine receptor 1A antagonist
mianserin,5-hydroxytryptamine receptor 1A inhibitor
mianserin,5-hydroxytryptamine receptor 1A binder
mianserin,5-hydroxytryptamine receptor 1A agonist
mianserin,Alpha-2C adrenergic receptor antagonist
mianserin,Alpha-2C adrenergic receptor inhibitor
mianserin,Alpha-2C adrenergic receptor agonist
mianserin,5-hydroxytryptamine receptor 2B antagonist
mianserin,5-hydroxytryptamine receptor 2B inhibitor
mianserin,5-hydroxytryptamine receptor 2B binder
mianserin,5-hydroxytryptamine receptor 2B agonist
mianserin,5-hydroxytryptamine receptor 1F agonist
mianserin,Alpha-2B adrenergic receptor antagonist
mianserin,Alpha-2B adrenergic receptor inhibitor
mianserin,Alpha-2B adrenergic receptor binder
mianserin,Alpha-2B adrenergic receptor agonist
mianserin,Dopamine D3 receptor antagonist
mianserin,Dopamine D3 receptor inhibitor
mianserin,Dopamine D3 receptor binder
mianserin,Dopamine D3 receptor agonist
mianserin,Kappa-type opioid receptor antagonist
mianserin,Kappa-type opioid receptor inhibitor
mianserin,Kappa-type opioid receptor binder
mianserin,Kappa-type opioid receptor agonist
mianserin,Sodium-dependent dopamine transporter antagonist
mianserin,Sodium-dependent dopamine transporter inhibitor
mianserin,Sodium-dependent dopamine transporter binder
mianserin,Sodium-dependent dopamine transporter agonist
mianserin,5-hydroxytryptamine receptor 7 antagonist
mianserin,5-hydroxytryptamine receptor 7 inhibitor
mianserin,5-hydroxytryptamine receptor 7 binder
mianserin,5-hydroxytryptamine receptor 7 agonist
mianserin,Dopamine D2 receptor antagonist
mianserin,Dopamine D2 receptor inhibitor
mianserin,Dopamine D2 receptor binder
mianserin,Dopamine D2 receptor agonist
mianserin,5-hydroxytryptamine receptor 6 antagonist
mianserin,5-hydroxytryptamine receptor 6 inhibitor
mianserin,5-hydroxytryptamine receptor 6 binder
mianserin,Alpha-1 adrenergic receptors antagonist
mianserin,Alpha-1 adrenergic receptors inhibitor
mianserin,Alpha-1 adrenergic receptors binder
mianserin,Alpha-1 adrenergic receptors agonist
mianserin,D(1) dopamine receptor antagonist
mianserin,D(1) dopamine receptor inhibitor
mianserin,D(1) dopamine receptor binder
mianserin,D(1) dopamine receptor agonist
romidepsin,Histone deacetylase 2 inhibitor
lasofoxifene,Estrogen receptor alpha antagonist
lasofoxifene,Estrogen receptor alpha agonist
lasofoxifene,Estrogen receptor beta agonist
tapentadol,Mu-type opioid receptor agonist
tapentadol,Mu-type opioid receptor inhibitor
tapentadol,Sodium-dependent noradrenaline transporter agonist
tapentadol,Sodium-dependent noradrenaline transporter inhibitor
tapentadol,Kappa-type opioid receptor agonist
tapentadol,Kappa-type opioid receptor inhibitor
tapentadol,Delta-type opioid receptor agonist
tapentadol,5-hydroxytryptamine receptor 3A agonist
tapentadol,5-hydroxytryptamine receptor 3A inhibitor
tapentadol,Sodium-dependent serotonin transporter agonist
tapentadol,Sodium-dependent serotonin transporter inhibitor
silodosin,Alpha-1A adrenergic receptor antagonist
silodosin,Alpha-1D adrenergic receptor antagonist
silodosin,Alpha-1B adrenergic receptor antagonist
asenapine,5-hydroxytryptamine receptor 1A antagonist
asenapine,5-hydroxytryptamine receptor 1B antagonist
asenapine,5-hydroxytryptamine receptor 2A antagonist
asenapine,5-hydroxytryptamine receptor 2B antagonist
asenapine,5-hydroxytryptamine receptor 2C antagonist
asenapine,5-hydroxytryptamine receptor 6 antagonist
asenapine,5-hydroxytryptamine receptor 7 antagonist
asenapine,Dopamine D2 receptor antagonist
asenapine,Dopamine D3 receptor antagonist
asenapine,Dopamine D4 receptor antagonist
asenapine,Dopamine D1 receptor antagonist
asenapine,Alpha-1A adrenergic receptor antagonist
asenapine,Alpha-2A adrenergic receptor antagonist
asenapine,Alpha-2B adrenergic receptor antagonist
asenapine,Alpha-2C adrenergic receptor antagonist
asenapine,Histamine H1 receptor antagonist
asenapine,Histamine H2 receptor antagonist
asenapine,Beta-1 adrenergic receptor antagonist
asenapine,Beta-2 adrenergic receptor antagonist
nalmefene,Mu-type opioid receptor antagonist
nalmefene,Kappa-type opioid receptor antagonist
nalmefene,Kappa-type opioid receptor partial agonist
nalmefene,Delta-type opioid receptor antagonist
avanafil,"cGMP-specific 3',5'-cyclic phosphodiesterase inhibitor"
amisulpride,Dopamine D2 receptor antagonist
amisulpride,Dopamine D2 receptor agonist
amisulpride,Dopamine D3 receptor antagonist
amisulpride,Dopamine D3 receptor agonist
amisulpride,5-hydroxytryptamine receptor 7 antagonist
amisulpride,5-hydroxytryptamine receptor 7 agonist
amisulpride,5-hydroxytryptamine receptor 2A antagonist
amisulpride,5-hydroxytryptamine receptor 2A agonist
amisulpride,Mu-type opioid receptor antagonist
amisulpride,Mu-type opioid receptor agonist
amisulpride,Delta-type opioid receptor antagonist
amisulpride,Delta-type opioid receptor agonist
amisulpride,Kappa-type opioid receptor antagonist
amisulpride,Kappa-type opioid receptor agonist
bazedoxifene,Estrogen receptor alpha antagonist
bazedoxifene,Estrogen receptor alpha agonist
bazedoxifene,Estrogen receptor beta agonist
pazopanib,Vascular endothelial growth factor receptor 2 inhibitor
pazopanib,Platelet-derived growth factor receptor beta inhibitor
pazopanib,Mast/stem cell growth factor receptor Kit inhibitor
bosutinib,Tyrosine-protein kinase ABL1 inhibitor
axitinib,Vascular endothelial growth factor receptor 2 inhibitor
vilazodone,Sodium-dependent serotonin transporter inhibitor
vilazodone,Sodium-dependent serotonin transporter agonist
vilazodone,5-hydroxytryptamine receptor 1A inhibitor
vilazodone,5-hydroxytryptamine receptor 1A agonist
betahistine,Histamine H1 receptor agonist
betahistine,Histamine H1 receptor antagonist
desvenlafaxine,Sodium-dependent noradrenaline transporter inhibitor
desvenlafaxine,Sodium-dependent serotonin transporter inhibitor
desvenlafaxine,Sodium-dependent dopamine transporter inhibitor
fesoterodine,Muscarinic acetylcholine receptor M3 antagonist
fesoterodine,Muscarinic acetylcholine receptor M4 antagonist
fesoterodine,Muscarinic acetylcholine receptor M1 antagonist
fesoterodine,Muscarinic acetylcholine receptor M2 antagonist
fesoterodine,Muscarinic acetylcholine receptor M5 antagonist
methacholine,Muscarinic acetylcholine receptor M3 agonist
methacholine,Muscarinic acetylcholine receptor M1 agonist
pralatrexate,Thymidylate synthase inhibitor
parecoxib,Prostaglandin G/H synthase 2 inhibitor
lurasidone,Dopamine D2 receptor antagonist
lurasidone,5-hydroxytryptamine receptor 2A antagonist
lurasidone,5-hydroxytryptamine receptor 7 antagonist
lurasidone,5-hydroxytryptamine receptor 1A antagonist
lurasidone,Alpha-2C adrenergic receptor antagonist
lurasidone,Alpha-2A adrenergic receptor antagonist
mirabegron,Beta-3 adrenergic receptor agonist
mirabegron,Beta-1 adrenergic receptor agonist
regorafenib,Vascular endothelial growth factor receptor 2 inhibitor
regorafenib,Mast/stem cell growth factor receptor Kit inhibitor
regorafenib,Platelet-derived growth factor receptor beta inhibitor
regorafenib,Tyrosine-protein kinase ABL1 inhibitor
aclidinium,Muscarinic acetylcholine receptor M1 antagonist
aclidinium,Muscarinic acetylcholine receptor M2 antagonist
aclidinium,Muscarinic acetylcholine receptor M3 antagonist
aclidinium,Muscarinic acetylcholine receptor M4 antagonist
aclidinium,Muscarinic acetylcholine receptor M5 antagonist
ponatinib,Tyrosine-protein kinase ABL1 inhibitor
ponatinib,Mast/stem cell growth factor receptor Kit inhibitor
ponatinib,Vascular endothelial growth factor receptor 2 inhibitor
pomalidomide,Prostaglandin G/H synthase 2 inhibitor
tibolone,Estrogen receptor alpha antagonist
tibolone,Estrogen receptor alpha agonist
umeclidinium,Muscarinic acetylcholine receptor M1 antagonist
umeclidinium,Muscarinic acetylcholine receptor M2 antagonist
umeclidinium,Muscarinic acetylcholine receptor M3 antagonist
umeclidinium,Muscarinic acetylcholine receptor M4 antagonist
umeclidinium,Muscarinic acetylcholine receptor M5 antagonist
homatropine,Muscarinic acetylcholine receptor M1 antagonist
homatropine,Muscarinic acetylcholine receptor M2 antagonist
homatropine,Muscarinic acetylcholine receptor M3 antagonist
homatropine,Muscarinic acetylcholine receptor M4 antagonist
homatropine,Muscarinic acetylcholine receptor M5 antagonist
tropisetron,5-hydroxytryptamine receptor 3A antagonist
lormetazepam,GABA(A) Receptor ligand
lormetazepam,GABA(A) Receptor Benzodiazepine Binding Site ligand
candesartan,Type-1 angiotensin II receptor antagonist
